0000034067--12-312026Q1falsehttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpensexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:EURboom:segmentboom:lawsuitboom:faciltyboom:issue00000340672026-01-012026-03-310000034067us-gaap:CommonStockMember2026-01-012026-03-310000034067boom:StockPurchaseRightsMember2026-01-012026-03-3100000340672026-04-2300000340672026-03-3100000340672025-12-3100000340672025-01-012025-03-310000034067us-gaap:CommonStockMember2025-12-310000034067us-gaap:AdditionalPaidInCapitalMember2025-12-310000034067us-gaap:RetainedEarningsMember2025-12-310000034067us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000034067us-gaap:TreasuryStockCommonMember2025-12-310000034067us-gaap:ParentMember2025-12-310000034067us-gaap:RetainedEarningsMember2026-01-012026-03-310000034067us-gaap:ParentMember2026-01-012026-03-310000034067us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000034067us-gaap:CommonStockMember2026-01-012026-03-310000034067us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310000034067us-gaap:TreasuryStockCommonMember2026-01-012026-03-310000034067us-gaap:CommonStockMember2026-03-310000034067us-gaap:AdditionalPaidInCapitalMember2026-03-310000034067us-gaap:RetainedEarningsMember2026-03-310000034067us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000034067us-gaap:TreasuryStockCommonMember2026-03-310000034067us-gaap:ParentMember2026-03-310000034067us-gaap:CommonStockMember2024-12-310000034067us-gaap:AdditionalPaidInCapitalMember2024-12-310000034067us-gaap:RetainedEarningsMember2024-12-310000034067us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000034067us-gaap:TreasuryStockCommonMember2024-12-310000034067us-gaap:ParentMember2024-12-3100000340672024-12-310000034067us-gaap:RetainedEarningsMember2025-01-012025-03-310000034067us-gaap:ParentMember2025-01-012025-03-310000034067us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000034067us-gaap:CommonStockMember2025-01-012025-03-310000034067us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000034067us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000034067us-gaap:CommonStockMember2025-03-310000034067us-gaap:AdditionalPaidInCapitalMember2025-03-310000034067us-gaap:RetainedEarningsMember2025-03-310000034067us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000034067us-gaap:TreasuryStockCommonMember2025-03-310000034067us-gaap:ParentMember2025-03-3100000340672025-03-310000034067boom:ArcadiaProductsSegmentMember2025-12-310000034067boom:DynaEnergeticsSegmentMember2025-12-310000034067boom:NobelCladSegmentMember2025-12-310000034067boom:ArcadiaProductsSegmentMember2026-01-012026-03-310000034067boom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067boom:NobelCladSegmentMember2026-01-012026-03-310000034067boom:ArcadiaProductsSegmentMember2026-03-310000034067boom:DynaEnergeticsSegmentMember2026-03-310000034067boom:NobelCladSegmentMember2026-03-310000034067boom:ArcadiaProductsLLCMember2021-12-230000034067boom:RedeemableNoncontrollingInterestHolderMember2026-03-310000034067srt:MinimumMember2026-01-012026-03-310000034067srt:MaximumMember2026-01-012026-03-310000034067us-gaap:OtherCurrentAssetsMember2026-03-310000034067us-gaap:OtherCurrentAssetsMember2025-12-310000034067us-gaap:OtherNoncurrentAssetsMember2026-03-310000034067us-gaap:OtherNoncurrentAssetsMember2025-12-310000034067us-gaap:OtherCurrentLiabilitiesMember2026-03-310000034067us-gaap:OtherCurrentLiabilitiesMember2025-12-310000034067us-gaap:OtherNoncurrentLiabilitiesMember2026-03-310000034067us-gaap:OtherNoncurrentLiabilitiesMember2025-12-310000034067us-gaap:FairValueInputsLevel2Member2026-03-310000034067us-gaap:FairValueInputsLevel2Member2025-12-310000034067us-gaap:CustomerRelationshipsMember2026-03-310000034067us-gaap:TrademarksAndTradeNamesMember2026-03-310000034067us-gaap:CustomerRelationshipsMember2025-12-310000034067us-gaap:TrademarksAndTradeNamesMember2025-12-310000034067boom:CreditAgreementFacilityMemberus-gaap:RevolvingCreditFacilityMember2026-03-310000034067boom:CreditAgreementFacilityMemberus-gaap:RevolvingCreditFacilityMember2025-12-310000034067boom:CreditAgreementFacilityMemberboom:TermLoanFacilityMember2026-03-310000034067boom:CreditAgreementFacilityMemberboom:TermLoanFacilityMember2025-12-310000034067boom:EuropeanLineOfCreditMember2026-03-310000034067boom:EuropeanLineOfCreditMember2025-12-310000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMember2024-02-050000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMember2024-02-060000034067us-gaap:RevolvingCreditFacilityMemberboom:CreditAgreementFacilityMember2024-02-060000034067boom:TermLoanFacilityMemberboom:CreditAgreementFacilityMember2024-02-060000034067boom:DelayedDrawTermLoanFacilityMemberboom:CreditAgreementFacilityMember2024-02-060000034067boom:TermLoanFacilityMemberboom:CreditAgreementFacilityMemberboom:DebtAmortizationPeriodTwoMember2024-02-060000034067boom:TermLoanFacilityMemberboom:CreditAgreementFacilityMemberboom:DebtAmortizationPeriodThreeMember2024-02-060000034067us-gaap:RevolvingCreditFacilityMemberboom:CreditAgreementFacilityMemberus-gaap:SecuredDebtMember2026-03-310000034067us-gaap:RevolvingCreditFacilityMemberboom:CreditAgreementFacilityMemberus-gaap:SecuredDebtMember2025-12-310000034067boom:TermLoanFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberboom:CreditAgreementFacilityMembersrt:MinimumMember2026-01-012026-03-310000034067boom:TermLoanFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberboom:CreditAgreementFacilityMembersrt:MaximumMember2026-01-012026-03-310000034067boom:TermLoanFacilityMemberus-gaap:BaseRateMemberboom:CreditAgreementFacilityMembersrt:MinimumMember2026-01-012026-03-310000034067boom:TermLoanFacilityMemberus-gaap:BaseRateMemberboom:CreditAgreementFacilityMembersrt:MaximumMember2026-01-012026-03-310000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMember2026-01-012026-03-310000034067boom:ArcadiaProductsLLCMember2025-06-100000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMember2025-06-102025-06-100000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMember2025-06-092025-06-090000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMemberboom:QuarterEndedSeptember302025Member2025-06-102025-06-100000034067us-gaap:LineOfCreditMemberboom:CreditAgreementFacilityMemberboom:QuarterEndedDecember312025AndThereafterMember2025-06-102025-06-100000034067us-gaap:LineOfCreditMemberboom:EuropeanLineOfCreditMember2026-03-310000034067us-gaap:LineOfCreditMemberboom:EuropeanLineOfCreditMember2025-12-310000034067boom:A2024RightsMemberus-gaap:SeriesBPreferredStockMember2024-06-050000034067boom:A2024RightsMember2024-06-052024-06-050000034067boom:A2025RightsMember2025-05-302025-05-300000034067boom:A2025RightsMemberus-gaap:SubsequentEventMember2026-04-242026-04-240000034067boom:ArcadiaProductsMember2021-12-310000034067us-gaap:OperatingSegmentsMemberboom:ArcadiaProductsSegmentMember2026-01-012026-03-310000034067us-gaap:OperatingSegmentsMemberboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067us-gaap:OperatingSegmentsMemberboom:NobelCladSegmentMember2026-01-012026-03-310000034067us-gaap:OperatingSegmentsMember2026-01-012026-03-310000034067us-gaap:MaterialReconcilingItemsMember2026-01-012026-03-310000034067us-gaap:OperatingSegmentsMemberboom:ArcadiaProductsSegmentMember2025-01-012025-03-310000034067us-gaap:OperatingSegmentsMemberboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067us-gaap:OperatingSegmentsMemberboom:NobelCladSegmentMember2025-01-012025-03-310000034067us-gaap:OperatingSegmentsMember2025-01-012025-03-310000034067us-gaap:MaterialReconcilingItemsMember2025-01-012025-03-310000034067boom:ArcadiaProductsSegmentMember2025-01-012025-03-310000034067us-gaap:CorporateNonSegmentMember2026-01-012026-03-310000034067us-gaap:CorporateNonSegmentMember2025-01-012025-03-310000034067boom:WestMemberboom:ArcadiaProductsSegmentMember2026-01-012026-03-310000034067boom:WestMemberboom:ArcadiaProductsSegmentMember2025-01-012025-03-310000034067boom:SouthMemberboom:ArcadiaProductsSegmentMember2026-01-012026-03-310000034067boom:SouthMemberboom:ArcadiaProductsSegmentMember2025-01-012025-03-310000034067boom:NortheastMemberboom:ArcadiaProductsSegmentMember2026-01-012026-03-310000034067boom:NortheastMemberboom:ArcadiaProductsSegmentMember2025-01-012025-03-310000034067boom:MidwestMemberboom:ArcadiaProductsSegmentMember2026-01-012026-03-310000034067boom:MidwestMemberboom:ArcadiaProductsSegmentMember2025-01-012025-03-310000034067country:USboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:USboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:TRboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:TRboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:CAboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:CAboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:KWboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:KWboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:EGboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:EGboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:IDboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:IDboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:OMboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067country:OMboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067boom:RestOfTheWorldMemberboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067boom:RestOfTheWorldMemberboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067boom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067country:CNboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:CNboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:USboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:USboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:SEboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:SEboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:CAboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:CAboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:AUboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:AUboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:AEboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:AEboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:NLboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:NLboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:DEboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:DEboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:FRboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:FRboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:BEboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:BEboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:SAboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:SAboom:NobelCladSegmentMember2025-01-012025-03-310000034067country:ATboom:NobelCladSegmentMember2026-01-012026-03-310000034067country:ATboom:NobelCladSegmentMember2025-01-012025-03-310000034067boom:RestOfTheWorldMemberboom:NobelCladSegmentMember2026-01-012026-03-310000034067boom:RestOfTheWorldMemberboom:NobelCladSegmentMember2025-01-012025-03-310000034067boom:NobelCladSegmentMember2025-01-012025-03-310000034067boom:OneCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067boom:OneCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberboom:DynaEnergeticsSegmentMember2025-01-012025-03-310000034067boom:OneCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberboom:DynaEnergeticsSegmentMember2026-01-012026-03-310000034067boom:OneCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberboom:DynaEnergeticsSegmentMember2025-01-012025-12-310000034067us-gaap:ForeignExchangeForwardMember2026-03-310000034067us-gaap:ForeignExchangeForwardMember2025-12-310000034067us-gaap:ForeignExchangeForwardMember2026-01-012026-03-310000034067us-gaap:ForeignExchangeForwardMember2025-01-012025-03-3100000340672025-02-052025-02-0500000340672024-02-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
OR
☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______ TO ______
Commission file number 001-14775
DMC GLOBAL INC.
(Exact name of Registrant as Specified in its Charter) | | | | | | | | |
Delaware | | 84-0608431 |
| (State of Incorporation or Organization) | | (I.R.S. Employer Identification No.) |
11800 Ridge Parkway, Suite 300, Broomfield, Colorado 80021
(Address of principal executive offices, including zip code)
(303) 665-5700
(Registrant’s telephone number, including area code)
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol | | Name of exchange on which registered |
Common Stock, $0.05 Par Value | | BOOM | | The Nasdaq Global Select Market |
| Stock Purchase Rights | | | | The Nasdaq Global Select Market |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | |
Large accelerated filer ☐ | | Accelerated filer ☑ |
Non-accelerated filer ☐ | | Smaller reporting company ☐ |
| | Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 under the Act). Yes ☐ No ☑
The number of shares of Common Stock outstanding was 20,468,807 as of April 23, 2026.
CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS
This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We intend the forward-looking statements throughout this quarterly report on Form 10-Q to be covered by the safe harbor provisions for forward-looking statements. Statements contained in this report which are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from projected results. These statements can sometimes be identified by our use of forward-looking words such as “may,” “believe,” “plan,” “anticipate,” “estimate,” “expect,” “intend,” “seek,” and other phrases of similar meaning. Such statements include, but are not limited to, expectations regarding the impact of volatility of energy markets, the conflict between the United States, Israel, and Iran and related geopolitical instability, evolving global tariff policies on sales and profitability, tariff recoverability, market-responsive initiatives at Arcadia Products, cost reduction and market share expansion initiatives at DynaEnergetics, order activity improvements and shipment timing at NobelClad, market opportunities at NobelClad, our ability to access capital markets transactions in the future, the availability of funds to support our liquidity position and our expected future liquidity position. The forward-looking information is based on information available as of the date of this quarterly report and on numerous assumptions and developments that are not within our control. Although we believe that our expectations as expressed in these forward-looking statements are reasonable, we cannot assure you that our expectations will turn out to be correct. Factors that could cause actual results to differ materially include, but are not limited to, those factors referenced in our Annual Report on Form 10-K for the year ended December 31, 2025 and this Quarterly Report on Form 10-Q and other potential factors, including: geopolitical and economic instability, including recessions or depressions; inflation; supply chain delays and disruptions; the availability and cost of energy; transportation disruptions; the ability to obtain new contracts at attractive prices; the size and timing of customer orders and shipments; product pricing and margins; our ability to realize sales from our backlog; fluctuations in customer demand; fluctuations in foreign currencies; competitive factors; the timely completion of contracts; the timing and size of expenditures; the timely receipt of government approvals and permits; the price and availability of metal, aluminum, and other raw materials; fluctuations in tariffs or quotas; changes in laws and regulations, both domestic and foreign, impacting our business and the business of the end-market users we serve; the adequacy of local labor supplies at our facilities; changes in immigration laws or enforcement programs; current or future limits on manufacturing capacity at our various operations; the impact of pending or future litigation or regulatory matters; the availability and cost of funds; our ability to access our borrowing capacity under our credit facility or access the capital markets; the actions of activist stockholders; global economic conditions; and wars, terrorism and armed conflicts. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We undertake no obligation to publicly release the results of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
TABLE OF CONTENTS
Part I - FINANCIAL INFORMATION
ITEM 1. Condensed Consolidated Financial Statements
DMC GLOBAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in Thousands, Except Share and Per Share Data)
| | | | | | | | | | | |
| March 31, 2026 | | December 31, 2025 |
| (unaudited) | | |
| ASSETS | | | |
| Current assets: | | | |
| Cash and cash equivalents | $ | 31,511 | | | $ | 31,898 | |
| | | |
Accounts receivable, net of allowance for doubtful accounts of $9,850 and $9,790, respectively | 90,861 | | | 93,697 | |
| Inventories | 167,002 | | | 144,552 | |
| Prepaid expenses and other | 12,210 | | | 16,224 | |
| | | |
| | | |
| Total current assets | 301,584 | | | 286,371 | |
| Property, plant and equipment | 248,644 | | | 249,280 | |
| Less - accumulated depreciation | (124,237) | | | (121,922) | |
| Property, plant and equipment, net | 124,407 | | | 127,358 | |
| | | |
| Purchased intangible assets, net | 150,695 | | | 155,051 | |
| Deferred tax assets | 813 | | | 833 | |
| Other assets | 70,910 | | | 66,218 | |
| Total assets | $ | 648,409 | | | $ | 635,831 | |
| | | |
| LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY | | |
| Current liabilities: | | | |
| Accounts payable | $ | 58,386 | | | $ | 48,188 | |
| Accrued expenses | 12,797 | | | 12,375 | |
| | | |
| | | |
| Accrued income taxes | 2,087 | | | 4,289 | |
| Accrued employee compensation and benefits | 11,258 | | | 13,111 | |
| Contract liabilities | 27,048 | | | 22,568 | |
| Current portion of long-term debt | 3,750 | | | 3,438 | |
| Other current liabilities | 10,635 | | | 10,356 | |
| | | |
| Total current liabilities | 125,961 | | | 114,325 | |
| Long-term debt | 50,204 | | | 47,206 | |
| | | |
| Deferred tax liabilities | 117 | | | 475 | |
| Other long-term liabilities | 49,852 | | | 44,695 | |
| Total liabilities | 226,134 | | | 206,701 | |
Commitments and contingencies (Note 11) | | | |
| Redeemable noncontrolling interest | 187,080 | | | 187,080 | |
| Stockholders’ equity | | | |
Preferred stock, $0.05 par value; 4,000,000 shares authorized; no issued and outstanding shares | — | | | — | |
Common stock, $0.05 par value; 50,000,000 shares authorized; 21,482,407 and 21,497,468 shares issued, respectively | 1,074 | | | 1,075 | |
| Additional paid-in capital | 306,412 | | | 306,293 | |
Accumulated deficit | (19,517) | | | (13,452) | |
| Other cumulative comprehensive loss | (25,257) | | | (24,716) | |
Treasury stock, at cost, and company stock held for deferred compensation, at par; 1,007,256 and 979,334 shares, respectively | (27,517) | | | (27,150) | |
| | | |
| | | |
| Total stockholders’ equity | 235,195 | | | 242,050 | |
| Total liabilities, redeemable noncontrolling interest, and stockholders’ equity | $ | 648,409 | | | $ | 635,831 | |
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
DMC GLOBAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in Thousands, Except Share and Per Share Data)
(unaudited)
| | | | | | | | | | | | | | | |
| Three months ended March 31, | | |
| | 2026 | | 2025 | | | | |
| Net sales | $ | 135,595 | | | $ | 159,290 | | | | | |
| Cost of products sold | 110,152 | | | 118,091 | | | | | |
| Gross profit | 25,443 | | | 41,199 | | | | | |
| Costs and expenses: | | | | | | | |
| General and administrative expenses | 14,132 | | | 16,674 | | | | | |
| Selling and distribution expenses | 10,472 | | | 11,626 | | | | | |
| Amortization of purchased intangible assets | 4,356 | | | 4,763 | | | | | |
| | | | | | | |
| Strategic review and related expenses | — | | | 1,298 | | | | | |
| Restructuring expenses | 566 | | | 325 | | | | | |
| | | | | | | |
| Total costs and expenses | 29,526 | | | 34,686 | | | | | |
| Operating (loss) income | (4,083) | | | 6,513 | | | | | |
| Other expense: | | | | | | | |
| Other expense, net | (45) | | | (218) | | | | | |
| Interest expense, net | (1,461) | | | (1,699) | | | | | |
| (Loss) income before income taxes | (5,589) | | | 4,596 | | | | | |
| Income tax provision | 1,221 | | | 2,733 | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| Net (loss) income | $ | (6,810) | | | $ | 1,863 | | | | | |
| Less: Net (loss) income attributable to redeemable noncontrolling interest | (745) | | | 1,186 | | | | | |
| Net (loss) income attributable to DMC Global Inc. stockholders | $ | (6,065) | | | $ | 677 | | | | | |
| | | | | | | |
| Net (loss) income per share attributable to DMC Global Inc. stockholders: | | | | |
| Basic | $ | (0.34) | | | $ | 0.04 | | | | | |
| Diluted | $ | (0.34) | | | $ | 0.04 | | | | | |
| Weighted average shares outstanding: | | | | | | | |
| Basic | 20,066,158 | | | 19,812,161 | | | | | |
| Diluted | 20,066,158 | | | 19,816,281 | | | | | |
| | | | | | | |
| | | | | | | |
Reconciliation to net (loss) income attributable to DMC Global Inc. stockholders after adjustment of redeemable noncontrolling interest for purposes of calculating earnings per share
| | | | | | | | | | | | | | | |
| Three months ended March 31, | | |
| 2026 | | 2025 | | | | |
| Net (loss) income attributable to DMC Global Inc. stockholders | $ | (6,065) | | | $ | 677 | | | | | |
| Adjustment of redeemable noncontrolling interest | (735) | | | 81 | | | | | |
| Net (loss) income attributable to DMC Global Inc. stockholders after adjustment of redeemable noncontrolling interest | $ | (6,800) | | | $ | 758 | | | | | |
| | | | | | | |
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
DMC GLOBAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(Amounts in Thousands)
(unaudited)
| | | | | | | | | | | | | | | |
| Three months ended March 31, | | |
| | 2026 | | 2025 | | | | |
| Net (loss) income | $ | (6,810) | | | $ | 1,863 | | | | | |
| | | | | | | |
| Change in cumulative foreign currency translation adjustment | (541) | | | 1,174 | | | | | |
| Other comprehensive (loss) income | $ | (7,351) | | | $ | 3,037 | | | | | |
| | | | | | | |
| Less: comprehensive (loss) income attributable to redeemable noncontrolling interest | (745) | | | 1,186 | | | | | |
| | | | | | | |
| Comprehensive (loss) income attributable to DMC Global Inc. stockholders | $ | (6,606) | | | $ | 1,851 | | | | | |
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
DMC GLOBAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND REDEEMABLE NONCONTROLLING INTEREST
(Amounts in Thousands, Except Share Data)
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Other | | Treasury Stock, at cost, and | | Total | | Redeemable |
| | | | | | Additional | | Accumulated | | Cumulative | | Company Stock Held for | | DMC Global Inc. | | Non- |
| | Common Stock | | Paid-In | | | Comprehensive | | Deferred Compensation, at par | | Stockholders’ | | Controlling |
| | Shares | | Amount | | Capital | | Deficit | | Loss | | Shares | | Amount | | Equity | | Interest |
| Balances, December 31, 2025 | 21,497,468 | | | $ | 1,075 | | | $ | 306,293 | | | $ | (13,452) | | | $ | (24,716) | | | (979,334) | | | $ | (27,150) | | | $ | 242,050 | | | $ | 187,080 | |
| Net loss | — | | | — | | | — | | | (6,065) | | | — | | | — | | | — | | | (6,065) | | | (745) | |
| Change in cumulative foreign currency translation adjustment | — | | | — | | | — | | | — | | | (541) | | | — | | | — | | | (541) | | | — | |
| Share activity in connection with stock compensation plans | (15,061) | | | (1) | | | 1 | | | — | | | — | | | — | | | — | | | — | | | — | |
| Stock-based compensation | — | | | — | | | 853 | | | — | | | — | | | — | | | — | | | 853 | | | 10 | |
| | | | | | | | | | | | | | | | | |
| Adjustment of redeemable noncontrolling interest | — | | | — | | | (735) | | | — | | | — | | | — | | | — | | | (735) | | | 735 | |
| Treasury stock activity | — | | | — | | | — | | | — | | | — | | | (27,922) | | | (367) | | | (367) | | | — | |
| Balances, March 31, 2026 | 21,482,407 | | | $ | 1,074 | | | $ | 306,412 | | | $ | (19,517) | | | $ | (25,257) | | | (1,007,256) | | | $ | (27,517) | | | $ | 235,195 | | | $ | 187,080 | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Other | | Treasury Stock, at cost, and | | Total | | Redeemable |
| | | | | | Additional | | | | Cumulative | | Company Stock Held for | | DMC Global Inc. | | Non- |
| | Common Stock | | Paid-In | | Retained | | Comprehensive | | Deferred Compensation, at par | | Stockholders’ | | Controlling |
| | Shares | | Amount | | Capital | | Earnings | | Loss | | Shares | | Amount | | Equity | | Interest |
| Balances, December 31, 2024 | 21,083,184 | | | $ | 1,054 | | | $ | 305,460 | | | $ | — | | | $ | (29,560) | | | (820,322) | | | $ | (25,983) | | | $ | 250,971 | | | $ | 187,080 | |
| Net income | — | | | — | | | — | | | 677 | | | — | | | — | | | — | | | 677 | | | 1,186 | |
| Change in cumulative foreign currency translation adjustment | — | | | — | | | — | | | — | | | 1,174 | | | — | | | — | | | 1,174 | | | — | |
Share activity in connection with stock compensation plans | 319,846 | | | 16 | | | (13) | | | — | | | — | | | (59,796) | | | (3) | | | — | | | — | |
| Stock-based compensation | — | | | — | | | 1,504 | | | — | | | — | | | — | | | — | | | 1,504 | | | 95 | |
| Distribution to redeemable noncontrolling interest holder | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (1,200) | |
| Adjustment of redeemable noncontrolling interest | — | | | — | | | — | | | 81 | | | — | | | — | | | — | | | 81 | | | (81) | |
| Treasury stock activity | — | | | — | | | — | | | — | | | — | | | (32,190) | | | (484) | | | (484) | | | — | |
| Balances, March 31, 2025 | 21,403,030 | | | $ | 1,070 | | | $ | 306,951 | | | $ | 758 | | | $ | (28,386) | | | (912,308) | | | $ | (26,470) | | | $ | 253,923 | | | $ | 187,080 | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
DMC GLOBAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in Thousands)
(unaudited)
| | | | | | | | | | | |
| Three months ended March 31, |
| | 2026 | | 2025 |
| Cash flows from operating activities: | | | |
| Net (loss) income | $ | (6,810) | | | $ | 1,863 | |
| Adjustments to reconcile net (loss) income to net cash from operating activities: | | |
| | | |
| Depreciation | 3,715 | | | 3,660 | |
| Amortization of purchased intangible assets | 4,356 | | | 4,763 | |
| Amortization of deferred debt issuance costs | 231 | | | 217 | |
| | | |
| Stock-based compensation | 863 | | | 1,599 | |
| | | |
| Bad debt expense | 61 | | | 706 | |
| Deferred income taxes | (339) | | | 22 | |
| | | |
| | | |
Other, net | (119) | | | 555 | |
| | | |
| Change in: | | | |
| Accounts receivable, net | 2,350 | | | (10,572) | |
| Inventories | (22,880) | | | 4,557 | |
| Prepaid expenses and other | 7,899 | | | 3,239 | |
| Accounts payable | 11,029 | | | 203 | |
| Contract liabilities | 4,587 | | | (4,758) | |
| | | |
| Accrued expenses and other liabilities | (7,322) | | | (1,566) | |
| Net cash (used in) provided by operating activities | (2,379) | | | 4,488 | |
| Cash flows from investing activities: | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| Acquisition of property, plant and equipment | (2,110) | | | (3,779) | |
| Proceeds from property, plant and equipment reimbursements | 847 | | | 426 | |
| Proceeds on sale of property, plant and equipment | — | | | 21 | |
| | | |
| Net cash used in investing activities | (1,263) | | | (3,332) | |
| Cash flows from financing activities: | | | |
| | | |
| Repayments on term loan | (625) | | | (625) | |
| Borrowings on revolving loans | 58,600 | | | 8,500 | |
| Repayments on revolving loans | (54,775) | | | (6,375) | |
| | | |
| | | |
| Distributions to redeemable noncontrolling interest holder | — | | | (1,151) | |
| | | |
| | | |
| | | |
| Treasury stock purchases | (367) | | | (484) | |
| | | |
| Net cash provided by (used in) financing activities | 2,833 | | | (135) | |
| | | |
| Effects of exchange rates on cash | 422 | | | (605) | |
| | | |
| Net (decrease) increase in cash and cash equivalents | (387) | | | 416 | |
| Cash and cash equivalents, beginning of the period | 31,898 | | | 14,289 | |
| Cash and cash equivalents, end of the period | $ | 31,511 | | | $ | 14,705 | |
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
DMC GLOBAL INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in Thousands, Except Share and Per Share Data)
(unaudited)
1. BASIS OF PRESENTATION
The information included in the Condensed Consolidated Financial Statements is unaudited but includes all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the interim periods presented. Certain information and footnote disclosures, including critical and significant accounting policies normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted for this quarterly presentation. These Condensed Consolidated Financial Statements should be read in conjunction with the financial statements that are included in our Annual Report filed on Form 10-K for the year ended December 31, 2025.
2. SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
The Condensed Consolidated Financial Statements include the accounts of DMC Global Inc. (“DMC”, “we”, “us”, “our”, or the “Company”) and its controlled subsidiaries. All intercompany accounts, profits, and transactions have been eliminated in consolidation.
Accounts Receivable
The Company measures expected credit losses for its accounts receivable using a current expected credit loss model, which is based on historical experience, adjusted for current conditions and reasonable and supportable forecasts. The Company has disaggregated pools of accounts receivable balances by business, geography and/or customer risk profile and has used history and other experience to establish an allowance for credit losses at the time the receivable is recognized. To measure expected credit losses, we have elected to pool trade receivables by segment and analyze each segment’s accounts receivable balances as separate populations. Within each segment, receivables exhibit similar risk characteristics.
During the three months ended March 31, 2026, our expected loss rate reflects uncertainties in market conditions present in our businesses, including supply chain disruptions, continued volatility in oil and gas markets, elevated interest rates, as well as global geopolitical and economic instability. In addition, we reviewed receivables outstanding, including aged balances, and in circumstances where we are aware of a specific customer’s inability to meet its financial obligation to us, we recorded a specific allowance for credit losses against the amounts due, reducing the net receivable recognized to the amount we estimate will be collected. The offsetting expense is charged to “Selling and distribution expenses” in our Condensed Consolidated Statements of Operations. During the three months ended March 31, 2026 and 2025, net provisions of $61 and $706, respectively, were recorded.
The following table summarizes year-to-date activity in the allowance for credit losses on receivables from customers in each of our business segments:
| | | | | | | | | | | | | | | | | | | | | | | |
| Arcadia Products | | DynaEnergetics | | NobelClad | | DMC Global Inc. |
Allowance for doubtful accounts, December 31, 2025 | $ | 313 | | | $ | 9,445 | | | $ | 32 | | | $ | 9,790 | |
| | | | | | | |
| Current period provision for expected credit losses | 86 | | | 31 | | | — | | | 117 | |
| Write-offs charged against the allowance | — | | | — | | | — | | | — | |
| Recoveries of amounts previously reserved | (5) | | | (51) | | | — | | | (56) | |
| Impacts of foreign currency exchange rates and other | — | | | (1) | | | — | | | (1) | |
Allowance for doubtful accounts, March 31, 2026 | $ | 394 | | | $ | 9,424 | | | $ | 32 | | | $ | 9,850 | |
Contract Liabilities
At times, we require customers to make advanced payments prior to the shipment of their orders to help finance our inventory investment on large orders or keep customers’ credit limits at acceptable levels. Contract liabilities consisted of the following for the periods presented: | | | | | | | | | | | |
| March 31, 2026 | | December 31, 2025 |
Arcadia Products | $ | 11,022 | | | $ | 9,073 | |
| DynaEnergetics | 855 | | | 483 | |
| NobelClad | 15,171 | | | 13,012 | |
| Total | $ | 27,048 | | | $ | 22,568 | |
We generally expect to recognize the revenue associated with contract liabilities over a time period no longer than one year, but unforeseen circumstances can cause delays in shipments associated with contract liabilities, primarily supply chain delays and disruptions.
Redeemable Noncontrolling Interest
On December 23, 2021, DMC completed the acquisition of 60% of the membership interests in Arcadia Products, LLC, a Colorado limited liability company resulting from the conversion of Arcadia, Inc. (collectively, “Arcadia Products”). The limited liability company operating agreement for Arcadia Products (the “Operating Agreement”) contains a right for the Company to purchase the remaining interest in Arcadia Products from the minority interest holder on or after December 23, 2024 (“Call Option”). Similarly, the Operating Agreement originally permitted the minority interest holder of Arcadia Products the right to sell its remaining interest in Arcadia Products to the Company on or after December 23, 2024 (“Put Option”). On December 3, 2024, the Company and minority interest holder entered into an amendment to the Operating Agreement whereby the minority interest holder agreed not to exercise the Put Option until on or after September 6, 2026.
The purchase price for any interests sold pursuant to the Call Option or Put Option continues to be based upon a predefined calculation as included within the Operating Agreement. In connection with an exercise of the Call Option, the Operating Agreement would require payment of the purchase price in cash. However, in connection with the exercise of the Put Option, the Operating Agreement permits the Company the option to pay the purchase price in either cash, or 20% in cash and 80% in shares of a newly designated series of preferred stock (the “Put Preferred”) that would be authorized at that time. The terms of the Put Preferred, including the rights, powers and preferences thereof, are set forth in the Operating Agreement. The number of shares to be issued in connection with the Put Option (if the Company utilizes that payment mechanism) would be initially determined and valued at the volume weighted average trading price of the Company’s common stock over the 60 days preceding the delivery of the Put Option notice. The Put Preferred would be entitled to dividends at a rate of 3% per annum and would be convertible into one share of the Company’s common stock, subject to Nasdaq rules which generally prohibit private placements of equity securities with voting rights of 20% or more of a company’s pre-issuance voting power, including through convertible securities, without stockholder approval; the holder of the Put Preferred would not be allowed to participate in any such stockholder vote. The Company may redeem the Put Preferred at any time; however, beginning on June 23, 2027, the Company must begin proportionate annual redemptions of the Put Preferred and, in any event, the Put Preferred must be redeemed by the third anniversary of its issuance.
The Company initially accounted for the noncontrolling interest in Arcadia Products at its acquisition date fair value. We determined that neither the Call Option nor the Put Option meet the definition of a derivative as the Operating Agreement does not allow for contractual net settlement, the options cannot be settled outside the Operating Agreement through a market mechanism, and the underlying shares are deemed illiquid as they are not publicly traded and thus not considered readily convertible to cash. Additionally, the settlement price for both options is based upon a predefined calculation tied to adjusted earnings rather than a fixed price, and the formula is based upon a multiple of Arcadia Products’ average adjusted earnings over a three-year period, subject to a floor value as defined in the Operating Agreement which is based primarily upon a contractually-stated equity value. As such, we have concluded that the Call Option and Put Option are embedded within the noncontrolling interest and therefore do not represent freestanding instruments.
Given that the noncontrolling interest is subject to possible redemption with redemption rights that are not entirely within the control of the Company, we have concluded that the noncontrolling interest should be accounted for in accordance with ASC 480 Distinguishing Liabilities from Equity (“ASC 480”). The noncontrolling interest is also probable of redemption, as the only criteria for the security to become redeemable is the passage of time. As such, the redeemable noncontrolling interest is classified in temporary equity, separate from the stockholders’ equity section, in the Condensed Consolidated Balance Sheets.
At each balance sheet date subsequent to acquisition, two separate calculations must be performed to determine the value of the redeemable noncontrolling interest. First, the redeemable noncontrolling interest must be accounted for in accordance with ASC 810 Consolidation (“ASC 810”) whereby income (loss) and cash distributions attributable to the redeemable noncontrolling interest holder are ascribed. After this occurs, applicable provisions of ASC 480 must be considered to determine whether any further adjustment is necessary to increase the carrying value of the redeemable noncontrolling interest. An adjustment would only be necessary if the estimated settlement amount of the redeemable noncontrolling interest, per the terms of the Operating Agreement, exceeds the carrying value calculated in accordance with ASC 810. If such adjustment is required, the impact is immediately recorded to retained earnings and additional paid-in capital, upon absence of retained earnings, and therefore does not impact the Condensed Consolidated Statements of Operations or Comprehensive (Loss) Income. As of March 31, 2026, and December 31, 2025, the redeemable noncontrolling interest was $187,080, which is equal to the floor value per the Operating Agreement.
Promissory Note
In order to equalize after-tax consideration to the redeemable noncontrolling interest holder relative to an alternative transaction structure, immediately following the closing of the acquisition, the Company loaned $24,902 to the redeemable noncontrolling interest holder. The loan was evidenced by an unsecured promissory note, and the loan will be repaid out of proceeds from the sale of the redeemable noncontrolling interest holder’s interests in Arcadia Products, whether received upon exercise of the Put Option, the Call Option or upon sale to third parties permitted under the terms of the Operating Agreement. The loan must be repaid in full at the earlier of the exercise of the Put or Call Option, or by December 16, 2051, and has been recorded within “Other assets” in the Condensed Consolidated Balance Sheets.
Revenue Recognition
The Company’s revenues are derived from consideration paid by customers for tangible goods. The Company analyzes its different products by segment to determine the appropriate basis for revenue recognition. Revenue is not generated from sources other than contracts with customers and revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. There are no material upfront costs for operations that are incurred from contracts with customers.
Our rights to payments for goods transferred to customers within our DynaEnergetics and NobelClad business segments arise when control is transferred at a point in time and not on any other criteria. Our rights to payments for goods transferred to customers within our Arcadia Products business segment also predominantly arise when control is transferred at a point in time; however, at times, control of certain customized, project-based products passes to the customer over time. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 90 days across all of our segments. In instances when we require customers to make advanced payments prior to the shipment of their orders, we record a contract liability. We have determined that our contract liabilities do not include a significant financing component given the short duration between order initiation and order fulfillment within each of our segments. Refer to Note 9 “Business Segments” for disaggregated revenue disclosures.
See additional revenue recognition policy disclosures specific to each of our business segments within our Annual Report filed on Form 10-K for the year ended December 31, 2025.
Income Taxes
We recognize deferred tax assets and liabilities for the expected future income tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. Any effects of changes in income tax rates or tax laws are included in the provision for income taxes in the period of enactment. The deferred income tax impact of tax credits are recognized as an immediate adjustment to income tax expense. We recognize deferred tax assets for the expected future effects of all deductible temporary differences to the extent we believe these assets will more likely than not be realized. We record a valuation allowance when, based on current circumstances, it is more likely than not that all or a portion of the deferred tax assets will not be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, recent financial performance and existing valuation allowances, if any.
We recognize the tax benefits from uncertain tax positions only when it is more likely than not, based on the technical merits of the position, that the tax position will be sustained upon examination, including the resolution of any related appeals or litigation. The tax benefits recognized in the Condensed Consolidated Financial Statements from such a position are
measured as the largest benefit that is more likely than not to be realized upon ultimate resolution. We recognize interest and penalties related to uncertain tax positions in operating expense.
Earnings Per Share
In periods with net income, the Company computes earnings per share (“EPS”) using a two-class method, which is an earnings allocation formula that determines EPS for (i) each class of common stock (the Company has a single class of common stock), and (ii) participating securities according to dividends declared and participation rights in undistributed earnings. Restricted stock awards (“RSAs”) granted under the 2016 Omnibus Incentive Plan are considered participating securities in periods of net income as they receive non-forfeitable rights to dividends as common stock. RSAs do not participate in net losses. RSAs granted under the 2025 Omnibus Incentive Plan are non-participating securities as they do not receive non-forfeitable rights to dividends as common stock.
Basic EPS is calculated by dividing net income (loss) attributable to the Company’s stockholders after adjustment of redeemable noncontrolling interest and dividends, if applicable, by the weighted average number of common shares outstanding during the period. Net income (loss) available to common shareholders of the Company includes any adjustment to the redeemable noncontrolling interest as of the end of the period presented. Refer to the “Redeemable Noncontrolling Interest” section above for further discussion of the calculation of the adjustment of the redeemable noncontrolling interest. Diluted EPS adjusts basic EPS for the effects of RSAs, restricted stock units, performance share units and other potentially dilutive financial instruments (“dilutive securities”), only in the periods in which such effect is dilutive. The effect of the dilutive securities is reflected in diluted EPS by application of the more dilutive of (1) the treasury stock method or (2) the two-class method. For the applicable periods presented, diluted EPS using the two-class method was more dilutive than the treasury stock method; as such, only the two-class method has been included below.
| | | | | | | | | | | | | | | |
| Three months ended March 31, | | |
| 2026 | | 2025 | | | | |
| Net (loss) income attributable to DMC Global Inc. stockholders, as reported | $ | (6,065) | | | $ | 677 | | | | | |
| Adjustment of redeemable noncontrolling interest | (735) | | | 81 | | | | | |
| | | | | | | |
| Less: Undistributed net income available to participating securities | — | | | (24) | | | | | |
| Numerator for basic net (loss) income per share: | (6,800) | | | 734 | | | | | |
| Add: Undistributed net income allocated to participating securities | — | | | 24 | | | | | |
| Less: Undistributed net income reallocated to participating securities | — | | | (24) | | | | | |
| Numerator for diluted net (loss) income per share: | $ | (6,800) | | | $ | 734 | | | | | |
| Denominator: | | | | | | | |
| Weighted average shares outstanding for basic net (loss) income per share | 20,066,158 | | | 19,812,161 | | | | | |
Effect of dilutive securities (1) | — | | | 4,120 | | | | | |
| Weighted average shares outstanding for diluted net (loss) income per share | 20,066,158 | | | 19,816,281 | | | | | |
| Net (loss) income per share attributable to DMC Global Inc. stockholders | | | | | | | |
| Basic | $ | (0.34) | | | $ | 0.04 | | | | | |
| Diluted | $ | (0.34) | | | $ | 0.04 | | | | | |
(1) Given that we were in a net loss position for the three months ended March 31, 2026, all potentially dilutive shares were anti-dilutive and therefore excluded from the determination of diluted EPS. For the three months ended March 31, 2025, 71,813 shares were excluded as their effect would have been anti-dilutive.
Deferred Compensation Plan
The Company maintains a Non-Qualified Deferred Compensation Plan (the “Plan”) as part of its overall compensation package for certain employees. Until enrollment in the Plan was suspended effective January 1, 2025, participants were eligible to defer a portion of their annual salary, their annual incentive bonus, and their equity awards through the Plan on a tax-deferred basis. Deferrals into the Plan were not matched or subsidized by the Company, nor were they eligible for above-market or preferential earnings.
The Plan provides for deferred compensation obligations to be settled either by delivery of a fixed number of shares of DMC’s common stock or in cash, in accordance with participant contributions and elections. For deferred equity awards,
subsequent to equity award vesting and after a period prescribed by the Plan, participants previously could elect to diversify contributions of equity awards into other investment options available to Plan participants. Once diversified, such contributions are settled by delivery of cash.
The Company has established a grantor trust commonly known as a “rabbi trust” and contributed certain assets to partially satisfy the future obligations to participants in the Plan. These assets are subject to potential claims of the Company’s general creditors. The assets held in the trust primarily include company-owned life insurance (“COLI”) on certain current and former employees and money market funds. COLI is accounted for at the cash surrender value while money market funds held by the trust are accounted for at fair value.
Deferred unvested RSAs and deferred common stock held by the trust are reflected in the Condensed Consolidated Balance Sheets within “Treasury stock, at cost, and company stock held for deferred compensation, at par” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock.
Deferred compensation obligations that will be settled in cash are accounted for on an accrual basis in accordance with the terms of the Plan. These obligations are adjusted based on changes in value of the underlying investment options chosen by Plan participants. Deferred compensation obligations that will be settled by delivery of a fixed number of previously vested shares of the Company’s common stock are reflected in the Condensed Consolidated Statements of Stockholders’ Equity and Redeemable Noncontrolling Interest within “Common stock” at the par value of the common stock or unvested RSAs. These accounts are not adjusted for subsequent changes in the fair value of the common stock.
The balances related to the deferred compensation plan were as follows for the periods presented. The amounts included within “Prepaid expenses and other” and “Other current liabilities” pertain to scheduled distributions per the terms of the Plan that will occur within twelve months of March 31, 2026.
| | | | | | | | | | | | | | | | | | | | |
| | Balance Sheet location | | March 31, 2026 | | December 31, 2025 |
| Deferred compensation assets | | Prepaid expenses and other | | $ | 1,961 | | | $ | 1,854 | |
| Deferred compensation assets | | Other assets | | $ | 795 | | | $ | 2,515 | |
| Deferred compensation obligations | | Other current liabilities | | $ | 1,961 | | | $ | 1,854 | |
| Deferred compensation obligations | | Other long-term liabilities | | $ | 4,190 | | | $ | 5,858 | |
| | | | | | |
| | | | | | |
Fair Value of Financial Instruments
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We are required to use an established hierarchy for fair value measurements based upon the inputs to the valuation and the degree to which they are observable or not observable in the market. The three levels in the hierarchy are as follows:
•Level 1 — Inputs to the valuation based upon quoted prices (unadjusted) for identical assets or liabilities in active markets that are accessible as of the measurement date.
•Level 2 — Inputs to the valuation include quoted prices in either markets that are not active, or in active markets for similar assets or liabilities, inputs other than quoted prices that are observable, and inputs that are derived principally from or corroborated by observable market data.
•Level 3 — Inputs to the valuation that are unobservable inputs for the asset or liability.
The highest priority is assigned to Level 1 inputs and the lowest priority to Level 3 inputs.
The carrying value of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate their fair value. The carrying value of our revolving loans and term loan under our credit facility, as well as the European line of credit, when outstanding, also approximate their fair value because of the variable interest rate associated with these instruments, which reset each month at market interest rates. All of these account balances are considered Level 1 assets and liabilities.
Our foreign currency forward contracts are valued using quoted market prices or are determined using a yield curve model based on current market rates. As a result, we classify these instruments as Level 2 in the fair value hierarchy. Money
market funds of $12 and $688 as of March 31, 2026, and December 31, 2025, respectively, held to satisfy future deferred compensation obligations are valued based upon the market values of underlying securities and are classified as Level 2 assets in the fair value hierarchy.
We did not have any Level 3 assets or liabilities recorded as of March 31, 2026, or December 31, 2025.
Restructuring Expenses
Restructuring expenses are incurred from time to time to improve operational efficiency across our businesses. During the three months ended March 31, 2026, and 2025, we recorded total restructuring expenses of $566 and $325, respectively, related to employee severance associated with headcount reductions at Arcadia Products and DynaEnergetics.
Recent Accounting Pronouncements
In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). ASU 2024-03 requires public business entities to disclose more detailed information about the types of expense in commonly presented expense captions to provide investors with more transparent and detailed expense information. The guidance is effective for fiscal years beginning after December 15, 2026 on a prospective basis. Early adoption and retrospective application of the amendments are permitted. The Company is within the scope of this ASU and expects to adopt ASU 2024-03 on January 1, 2027.
We have considered all other recent accounting pronouncements issued, but not yet effective, and we do not expect any to have a material effect on the Company’s Condensed Consolidated Financial Statements.
3. INVENTORIES
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Significant cost elements included in inventory are raw materials, labor, freight, subcontract costs, and manufacturing overhead. As necessary, we write down inventory to its net realizable value by recording provisions for excess, slow moving and obsolete inventory. To determine provision amounts, we regularly review inventory quantities on hand and values, and compare them to estimates of future product demand, market conditions, production requirements and technological developments.
Inventories consisted of the following at March 31, 2026:
| | | | | | | | | | | | | | | | | | | | | | | |
| Arcadia Products | | DynaEnergetics | | NobelClad | | DMC Global Inc. |
| Raw materials | $ | 12,663 | | | $ | 19,739 | | | $ | 10,665 | | | $ | 43,067 | |
| Work-in-process | 8,297 | | | 12,831 | | | 16,334 | | | 37,462 | |
| Finished goods | 54,926 | | | 30,885 | | | 363 | | | 86,174 | |
| Supplies | — | | | — | | | 299 | | | 299 | |
| Total inventories | $ | 75,886 | | | $ | 63,455 | | | $ | 27,661 | | | $ | 167,002 | |
Inventories consisted of the following at December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | |
| Arcadia Products | | DynaEnergetics | | NobelClad | | DMC Global Inc. |
| Raw materials | $ | 9,382 | | | $ | 24,240 | | | $ | 9,060 | | | $ | 42,682 | |
| Work-in-process | 6,797 | | | 10,036 | | | 10,244 | | | 27,077 | |
| Finished goods | 50,257 | | | 23,942 | | | 314 | | | 74,513 | |
| Supplies | — | | | — | | | 280 | | | 280 | |
| Total inventories | $ | 66,436 | | | $ | 58,218 | | | $ | 19,898 | | | $ | 144,552 | |
4. PURCHASED INTANGIBLE ASSETS
Our purchased intangible assets consisted of the following at March 31, 2026: | | | | | | | | | | | | | | | | | |
| Gross | | Accumulated Amortization | | Net |
| | | | | |
| | | | | |
| Customer relationships | $ | 210,500 | | | $ | (75,536) | | | $ | 134,964 | |
| | | | | |
| Trademarks / Trade names | 22,000 | | | (6,269) | | | 15,731 | |
| Total intangible assets | $ | 232,500 | | | $ | (81,805) | | | $ | 150,695 | |
Our purchased intangible assets consisted of the following at December 31, 2025: | | | | | | | | | | | | | | | | | |
| Gross | | Accumulated Amortization | | Net |
| | | | | |
| Customer relationships | $ | 210,500 | | | $ | (71,546) | | | $ | 138,954 | |
| | | | | |
| Trademarks / Trade names | 22,000 | | | (5,903) | | | 16,097 | |
| Total intangible assets | $ | 232,500 | | | $ | (77,449) | | | $ | 155,051 | |
5. LEASES
The Company leases real properties for use in manufacturing and as administrative and sales offices, and leases automobiles and office equipment. Nearly all of the Company’s leasing arrangements are classified as operating leases. Right-of-use (“ROU”) asset and lease liability balances were as follows for the periods presented:
| | | | | | | | | | | |
| March 31, 2026 | | December 31, 2025 |
| ROU asset | $ | 43,194 | | | $ | 36,018 | |
| | | |
| Current lease liability | 8,561 | | | 8,337 | |
| Long-term lease liability | 38,725 | | | 31,805 | |
| Total lease liability | $ | 47,286 | | | $ | 40,142 | |
The ROU asset is reported in “Other assets” while the current lease liability is reported in “Other current liabilities” and the long-term lease liability is reported in “Other long-term liabilities” in the Company’s Condensed Consolidated Balance Sheets. Cash paid for operating lease liabilities is recorded as operating cash outflows in the Company’s Condensed Consolidated Statements of Cash Flows.
6. DEBT
Outstanding borrowings consisted of the following at:
| | | | | | | | | | | |
| March 31, 2026 | | December 31, 2025 |
| Syndicated credit agreement: | | | |
| U.S. Dollar revolving loan | $ | 10,200 | | | $ | 6,375 | |
| Term loan | 45,000 | | | 45,625 | |
| | | |
| | | |
| European line of credit | — | | | — | |
| Outstanding borrowings | 55,200 | | | 52,000 | |
| Less: debt issuance costs | (1,246) | | | (1,356) | |
| Total debt | 53,954 | | | 50,644 | |
| Less: current portion of long-term debt | (3,750) | | | (3,438) | |
| Long-term debt | $ | 50,204 | | | $ | 47,206 | |
Syndicated Credit Agreement
On February 6, 2024, the Company and certain domestic subsidiaries entered into an amendment (the “First Amendment”) to its existing credit agreement with a syndicate of banks, led by KeyBank National Association (the “credit
facility”). The First Amendment provided for certain changes to the credit facility and increased the maximum commitment amount from $200,000 to $300,000. The credit facility originally allowed for revolving loans of up to $200,000, a $50,000 term loan facility, and a $50,000 delayed draw term loan (“DDTL”) facility. On February 6, 2026, the ability of the Company to access the $50,000 DDTL facility expired per the terms of the First Amendment. The $50,000 term loan facility is payable in installments of $938 per quarter through March 31, 2028. Quarterly term loan payments increase to $1,250 from June 30, 2028, through December 31, 2028. A balloon payment for the outstanding term loan balance is due upon the credit facility maturity date of February 6, 2029. The credit facility retains a $100,000 accordion feature to increase the commitments under the revolving loan and/or by adding one or more term loans subject to approval by the applicable lenders. The credit facility is secured by certain assets of DMC including accounts receivable, inventory, and fixed assets, including Arcadia Products and its subsidiary, as well as guarantees and share pledges by DMC and its subsidiaries. The revolving loan can also be used to issue bank guarantees to customers to secure their advanced payments. As of March 31, 2026, and December 31, 2025, bank guarantees of $2,800 and $800, respectively, were secured.
Borrowings under the $200,000 revolving loan limit and $50,000 term loan can be in the form of Adjusted Daily Simple Secured Overnight Financing Rate (“SOFR”) loans or one month Adjusted Term SOFR loans. Additionally, U.S. dollar borrowings on the revolving loan can be in the form of Base Rate loans (Base Rate borrowings are based on the greater of the administrative agent’s Prime rate, an adjusted Federal Funds rate or an adjusted SOFR rate). SOFR loans bear interest at the applicable SOFR rate plus an applicable margin (varying from 2.25% to 3.25%). Base Rate loans bear interest at the defined Base Rate plus an applicable margin (varying from 1.25% to 2.25%).
The credit facility includes various covenants and restrictions, certain of which relate to the payment of dividends or other distributions to stockholders; redemption of capital stock; incurring additional indebtedness; mortgaging, pledging or disposition of major assets; and maintenance of specified ratios.
The leverage ratio is defined in the credit facility as the ratio of Consolidated Funded Indebtedness (as defined in the credit facility) on the last day of any trailing four quarter period to Consolidated EBITDA (as defined in the credit facility) for such period. The maximum leverage ratio permitted by our credit facility is 3.0 to 1.0; provided, however, that the Second Amendment (as defined below) provides for a temporary increase in the maximum leverage ratio under certain circumstances as described below.
The debt service coverage ratio is defined in the credit facility as the ratio of Consolidated EBITDA less the sum of capital distributions paid in cash (other than those made with respect to preferred stock issued under the Operating Agreement), Consolidated Unfunded Capital Expenditures (as defined in the credit facility), and net cash income taxes divided by the sum of cash interest expense, any dividends on the preferred stock paid in cash, and scheduled principal payments on funded indebtedness. Under our credit facility, the minimum debt service coverage ratio permitted is 1.25 to 1.0.
On June 10, 2025, the Company and certain domestic subsidiaries entered into an amendment to the credit facility (the “Second Amendment”). The Second Amendment provided for certain changes to the credit facility, including modifications to the Company’s financial covenants and applicable interest rates to assist with the possible acquisition of the remaining 40% minority interest in Arcadia Products. Key provisions of the Second Amendment include a temporary increase in the Company’s maximum leverage ratio to 3.5x adjusted EBITDA over the trailing 12 months — up from 3.0x — should either the Put Option or the Call Option be exercised. This elevated leverage limit will apply for the first two quarters following payment of the purchase price of the Put Option or the Call Option, followed by a reduction to 3.25x in the third quarter, and a return to 3.0x thereafter.
As of March 31, 2026, we were in compliance with all financial covenants and other provisions of our debt agreements.
European Line of Credit
We maintain a line of credit with a German bank with a borrowing capacity of €7,000 for our NobelClad and DynaEnergetics operations in Europe. This line of credit is also used to issue bank guarantees to customers to secure their advanced payments. As of March 31, 2026, and December 31, 2025, we had no outstanding borrowings under the line of credit, and bank guarantees of €2,876 and €3,074, respectively, were secured. The line of credit has open-ended terms and can be canceled by the bank at any time.
7. STOCKHOLDERS PROTECTION RIGHTS AGREEMENT
On June 5, 2024, the Company’s board of directors (the “Board”) adopted the Stockholder Protection Rights Agreement (the “Rights Agreement”) and declared a dividend of one right (“Right”) for each share of the Company’s common stock
outstanding at the close of business on June 17, 2024. One Right will also be issued together with each share of common stock issued by the Company after that date, but before the Separation Time (as defined in the Rights Agreement). Each Right initially represents the right to purchase one one-thousandth (0.001) of a share of Series B Participating Preferred Stock for $75.00, subject to adjustment and upon such terms and subject to the conditions set forth in the Rights Agreement. Rights will generally become exercisable if any person (or any persons acting as a group) acquires “Beneficial Ownership” (as defined in the Rights Agreement) of 10%, or 20% in the case of certain passive investors, or more of the Company’s outstanding common stock. If Rights become exercisable, all holders of Rights (other than the person, entity or group triggering the Rights Agreement, whose rights will become void and will not be exercisable) will have the right to purchase from the Company for $75.00, subject to certain potential adjustments, shares of the Company’s common stock having a market value of twice that amount.
On May 30, 2025, the Company entered into Amendment No. 1 to the Rights Agreement to extend the expiration time of the Rights for one year to June 4, 2026. On April 24, 2026, the Company entered into Amendment No. 2 to the Rights Agreement to extend the expiration time of the Rights for one year to June 4, 2027 (unless the Rights are earlier redeemed, exchanged or terminated in accordance with the terms and conditions of the Rights Agreement, as amended). Except for the extension of the expiration time, the Rights Agreement remains unaltered and in full force and effect. There is currently no impact on the Company’s Condensed Consolidated Financial Statements.
The Company’s Certificate of Incorporation authorizes the issuance of preferred stock. As of March 31, 2026, no preferred stock has been issued.
8. INCOME TAXES
The effective tax rate for each of the periods reported differs from the U.S. statutory rate primarily due to variation in contribution to consolidated pre-tax income (loss) from each jurisdiction for the respective periods, differences between the U.S. and foreign tax rates (which range from 20% to 32%), permanent differences between book and taxable income, and income or loss attributable to the redeemable noncontrolling interest holder.
Arcadia Products is treated as a partnership for U.S. tax purposes. With the exception of certain state taxes, income or loss flows through to the shareholders and is taxed at the shareholder level. Tax impacts related to income or loss from Arcadia Products that are included in consolidated pretax results but are attributable to the redeemable noncontrolling interest holder are not included in the consolidated income tax provision.
We assess the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use existing deferred tax assets. Additionally, a three-year cumulative loss at a consolidated financial statement level may be viewed as negative evidence impacting a jurisdiction that by itself is not in a three-year cumulative loss position. As of March 31, 2026, we were in a three-year cumulative loss position at the consolidated financial statement level, driven by historical losses in the U.S. primarily related to the impairment of Arcadia Products’ goodwill in 2024. Accordingly, we have maintained the previously established valuation allowance against the corresponding net deferred tax assets in the U.S. as of March 31, 2026. The Company will continue to monitor the realizability of deferred tax assets and the need for valuation allowances and will record adjustments in the period in which facts support such changes.
DMC files income tax returns in the U.S. federal jurisdiction, as well as various U.S. state and foreign jurisdictions. Our tax provisions reflect our best estimate of state, local, federal and foreign taxes. In 2024, tax audits in Germany of both our NobelClad and DynaEnergetics subsidiaries commenced for the years 2019 through 2021. While the audits are not unexpected, the outcome cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with our expectations, the Company could be required to adjust its provisions for income taxes in the period such resolution occurs.
9. BUSINESS SEGMENTS
Our business is organized into three segments: Arcadia Products, DynaEnergetics and NobelClad. In December 2021, DMC acquired a 60% controlling interest in Arcadia Products. Arcadia Products designs, engineers, fabricates, and finishes aluminum framing systems, windows, curtain walls, storefronts, entrance systems, and interior partitions to the commercial construction market. Additionally, Arcadia Products supplies customized windows and doors to the high-end residential construction market. DynaEnergetics designs, manufactures, markets, and sells perforating systems and associated hardware for the global oil and gas industry. NobelClad produces explosion-welded clad metal plates for use in the construction of corrosion resistant industrial processing equipment and specialized transition joints for commuter rail cars, ships, and liquified natural gas (“LNG”) processing equipment.
Our reportable segments are separately managed, strategic business units that offer different products. Each segment’s products are marketed to different customer types and require different manufacturing processes and technologies, and each segment has separate financial information available. The Chief Operating Decision Maker (“CODM”) uses segment operating income or loss to allocate resources (including employees, property, and financial or capital resources) for each segment in the budget and forecasting process and to assess ongoing performance on a monthly basis. The CODM does not review total assets by segment for purposes of assessing segment performance and allocating resources. As such, the disclosure of total assets by segment has not been included below. The accounting policies of our reportable segments are the same as those described in Note 2 “Significant Accounting Policies”.
Segment information is as follows for the three months ended March 31, 2026:
| | | | | | | | | | | | | | | | | | | | | | | |
| Arcadia Products | | DynaEnergetics | | NobelClad | | Total |
| Net sales | $ | 56,706 | | | $ | 59,547 | | | $ | 19,342 | | | $ | 135,595 | |
| Cost of products sold | 43,041 | | | 52,042 | | | 14,965 | | | 110,048 | |
| Gross profit | 13,665 | | | 7,505 | | | 4,377 | | | 25,547 | |
| | | | | | | |
| Stock-based compensation* | 24 | | | — | | | — | | | 24 | |
| General and administrative expenses | 6,367 | | | 2,640 | | | 1,168 | | | 10,175 | |
| Selling and distribution expenses | 4,425 | | | 3,882 | | | 2,157 | | | 10,464 | |
| Amortization of purchased intangible assets | 4,356 | | | — | | | — | | | 4,356 | |
| Restructuring expenses | 495 | | | 71 | | | — | | | 566 | |
| | | | | | | |
| Operating (loss) income | (2,002) | | | 912 | | | 1,052 | | | (38) | |
| Unallocated corporate expenses | | | | | | | (3,167) | |
| Unallocated stock-based compensation* | | | | | | | (878) | |
| Other expense, net | | | | | | | (45) | |
| Interest expense, net | | | | | | | (1,461) | |
| Loss before income taxes | | | | | | | (5,589) | |
| Income tax provision | | | | | | | 1,221 | |
| Net loss | | | | | | | $ | (6,810) | |
Segment information is as follows for the three months ended March 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | |
| Arcadia Products | | DynaEnergetics | | NobelClad | | Total |
| Net sales | $ | 65,580 | | | $ | 65,551 | | | $ | 28,159 | | | $ | 159,290 | |
| Cost of products sold | 45,219 | | | 52,740 | | | 20,062 | | | 118,021 | |
| Gross profit | 20,361 | | | 12,811 | | | 8,097 | | | 41,269 | |
| | | | | | | |
| Stock-based compensation* | 237 | | | — | | | — | | | 237 | |
| General and administrative expenses | 7,306 | | | 2,747 | | | 1,192 | | | 11,245 | |
| Selling and distribution expenses | 4,734 | | | 4,476 | | | 2,283 | | | 11,493 | |
| Amortization of purchased intangible assets | 4,763 | | | — | | | — | | | 4,763 | |
| Restructuring expenses | 325 | | | — | | | — | | | 325 | |
| | | | | | | |
| Operating income | 2,996 | | | 5,588 | | | 4,622 | | | 13,206 | |
| Unallocated corporate expenses | | | | | | | (5,367) | |
| Unallocated stock-based compensation* | | | | | | | (1,326) | |
| Other expense, net | | | | | | | (218) | |
| Interest expense, net | | | | | | | (1,699) | |
| Income before income taxes | | | | | | | 4,596 | |
| Income tax provision | | | | | | | 2,733 | |
| Net income | | | | | | | $ | 1,863 | |
* Stock-based compensation is not allocated to wholly owned segments DynaEnergetics and NobelClad. Stock-based compensation is allocated to the Arcadia Products segment as 60% of such expense is attributable to the Company, whereas the remaining 40% is attributable to the redeemable noncontrolling interest holder.
| | | | | | | | | | | | | | | |
| Three months ended March 31, | | |
| 2026 | | 2025 | | | | |
| Depreciation and amortization: | | | | | | | |
| Arcadia Products | $ | 5,385 | | | $ | 5,769 | | | | | |
| DynaEnergetics | 1,763 | | | 1,791 | | | | | |
| NobelClad | 841 | | | 794 | | | | | |
| Segment depreciation and amortization | 7,989 | | | 8,354 | | | | | |
| Corporate and other | 82 | | | 69 | | | | | |
| Consolidated depreciation and amortization | $ | 8,071 | | | $ | 8,423 | | | | | |
The disaggregation of revenue earned from contracts with customers is based on the geographic location of the customer. For Arcadia Products, net sales have been presented consistent with United States regional definitions as provided by the American Institute of Architects. For DynaEnergetics and NobelClad, all net sales are from products shipped from our manufacturing facilities and distribution centers located in the United States, Germany, and Canada. The following represents our net sales based on the geographic location of the customer for the periods presented:
Arcadia Products
| | | | | | | | | | | | | | | |
| Three months ended March 31, | | |
| 2026 | | 2025 | | | | |
| West | $ | 47,763 | | | $ | 56,360 | | | | | |
| South | 4,586 | | | 5,174 | | | | | |
| Northeast | 2,560 | | | 2,146 | | | | | |
| Midwest | 1,797 | | | 1,900 | | | | | |
| Total Arcadia Products | $ | 56,706 | | | $ | 65,580 | | | | | |
DynaEnergetics
| | | | | | | | | | | | | | | |
| | Three months ended March 31, | | |
| | 2026 | | 2025 | | | | |
| United States | $ | 48,605 | | | $ | 53,296 | | | | | |
| Turkey | 3,154 | | | 506 | | | | | |
| Canada | 1,595 | | | 3,813 | | | | | |
| Kuwait | 1,104 | | | 887 | | | | | |
| Egypt | 953 | | | 856 | | | | | |
| Indonesia | 623 | | | 1,114 | | | | | |
| Oman | — | | | 2,039 | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Rest of the world (1) | 3,513 | | | 3,040 | | | | | |
| Total DynaEnergetics | $ | 59,547 | | | $ | 65,551 | | | | | |
(1) Rest of the world does not include any individual country comprising sales greater than 2% of total DynaEnergetics revenue.
NobelClad
| | | | | | | | | | | | | | | |
| | Three months ended March 31, | | |
| 2026 | | 2025 | | | | |
| China | $ | 5,469 | | | $ | 29 | | | | | |
| United States | 4,615 | | | 8,962 | | | | | |
| Sweden | 2,769 | | | 713 | | | | | |
| Canada | 1,702 | | | 2,233 | | | | | |
| Australia | 757 | | | 521 | | | | | |
| United Arab Emirates | 728 | | | 975 | | | | | |
| Netherlands | 572 | | | 367 | | | | | |
| Germany | 539 | | | 9,750 | | | | | |
| France | 475 | | | 407 | | | | | |
| Belgium | 56 | | | 512 | | | | | |
| Saudi Arabia | 48 | | | 1,799 | | | | | |
| Austria | 13 | | | 469 | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Rest of the world (1) | 1,599 | | | 1,422 | | | | | |
| Total NobelClad | $ | 19,342 | | | $ | 28,159 | | | | | |
(1) Rest of the world does not include any individual country comprising sales greater than 2% of total NobelClad revenue.
During the three months ended March 31, 2026, and 2025, one DynaEnergetics customer accounted for approximately 23% and 26%, respectively, of consolidated net sales. Additionally, the same DynaEnergetics customer accounted for approximately 26% and 32% of consolidated accounts receivable as of March 31, 2026, and December 31, 2025, respectively.
10. DERIVATIVE INSTRUMENTS
We are exposed to foreign currency exchange risk resulting from fluctuations in exchange rates, primarily the U.S. dollar to the euro, the U.S. dollar to the Canadian dollar and, to a lesser extent, other currencies, arising from intercompany and third-party transactions entered into by our subsidiaries that are denominated in currencies other than their functional currency. Changes in exchange rates with respect to these transactions result in unrealized gains or losses if such transactions are unsettled at the end of the reporting period or realized gains or losses at settlement of the transaction. We use foreign currency forward contracts to offset foreign exchange rate fluctuations on foreign currency denominated asset and liability positions. None of these contracts are designated as accounting hedges, and all changes in the fair value of forward contracts are recognized in “Other expense, net” within our Condensed Consolidated Statements of Operations.
We execute derivatives with a specialized foreign exchange brokerage firm as well as other large financial institutions. The primary credit risk inherent in derivative agreements is the possibility that a loss may occur from the nonperformance of a counterparty to the agreements. We perform a review of the credit risk of our counterparties at the inception of the contract and
on an ongoing basis. We anticipate that our counterparties will be able to fully satisfy their obligations under the agreement but will take action if doubt arises regarding the counterparties’ ability to perform.
As of March 31, 2026, and December 31, 2025, the net notional amounts of forward contracts the Company held were $6,351 and $10,858, respectively. At March 31, 2026, and December 31, 2025, the fair value of outstanding forward contracts was $0.
The following table reflects the location and amount of net (losses) gains from our foreign currency contracts for the periods presented. These net (losses) gains offset foreign currency gains and losses recorded in the normal course of business, which are not shown below.
| | | | | | | | | | | | | | | | | | |
| | Three months ended March 31, | | |
| Derivative | Statements of Operations Location | 2026 | | 2025 | | | | |
| Foreign currency contracts | Other expense, net | $ | 7 | | | $ | 315 | | | | | |
| | | | | | | | |
11. COMMITMENTS AND CONTINGENCIES
Contingent Liabilities
The Company records an accrual for contingent liabilities when a loss is both probable and reasonably estimable. If some amount within a range of loss appears to be a better estimate than any other amount within the range, that amount is accrued. When no amount within a range of loss appears to be a better estimate than any other amount, the lowest amount in the range is accrued.
Legal Proceedings
In the ordinary course of its business, the Company is involved in a number of lawsuits and claims, both actual and potential. In addition to the matters discussed below, various other lawsuits, claims, and proceedings have been or may be instituted or asserted against the Company, including those pertaining to environmental, safety and health, commercial, tax, product liability, intellectual property infringement and employment matters, and other actions and claims arising out of the normal course of business. Although it is difficult to accurately predict the outcome of any such proceedings, based on facts currently available, management believes that the disposition of these other matters that are pending or asserted will not have a material adverse effect, individually or in the aggregate, on the financial position of the Company.
Stockholder Litigation
On December 6, 2024, Samuel Garson, individually and on behalf of a putative class, filed a securities class action lawsuit in the United States District Court for the District of Colorado (the “District Court”) against the Company and other defendants (collectively, the “Defendants”). The complaint asserted violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b5-1 promulgated thereunder on behalf of a putative class of all persons who purchased the Company’s securities between May 3, 2024, and November 4, 2024. In particular, the complaint alleged that the Defendants made false and misleading statements during the class period concerning the Company’s business resulting in injury to the purported class members. On January 27, 2025, a second securities class action lawsuit was filed in the District Court by Alessandro Laurent, individually and of behalf of a putative class, asserting substantially the same allegations, but on behalf of all purchasers of the Company’s securities between January 29, 2024 and November 4, 2024. Both complaints sought certification of a class of purchasers of the Company’s securities during the respective class periods and an award of damages, interest, costs and expenses (including attorney’s fees) to the respective plaintiffs and class members. On February 5, 2025, the District Court ordered the two lawsuits consolidated, and on June 23, 2025, the lead plaintiff in the consolidated case filed an amended complaint adding additional allegations within the class period. On August 22, 2025, the Defendants moved to dismiss all claims in the consolidated case. On March 20, 2026, the District Court granted the Defendants’ motion and dismissed all claims.
On June 6, 2025, Michael Lewis filed a related stockholder derivative lawsuit in the District Court against the Company as nominal defendant and certain directors and officers, alleging breaches of fiduciary duties under Delaware law and violations of Section 14(a) of the Exchange Act, based in significant part on the allegations made in the Garson and Laurent complaints. On July 16, 2025, Lee Runey filed another related stockholder derivative lawsuit, also in the District Court, against the Company as nominal defendant and certain directors and officers, alleging breaches of fiduciary duties and other similar claims under Delaware law as well as violations of Section 14(a) of the Exchange Act, based in significant part on the allegations made
in Lewis and the amended complaint in Garson. On August 23, 2025, the parties in both derivative cases jointly requested that the District Court consolidate and stay the derivative cases until after a ruling is issued on the pending Garson motion to dismiss, and the District Court granted such request on October 14, 2025. On April 2, 2026, upon the District Court’s grant of the Defendants’ motion to dismiss, the parties in both derivative cases jointly requested, and the District Court granted, an extension of the stay until May 1, 2026.
The Company intends to vigorously defend itself against the foregoing actions.
Due to the nature of these matters and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any, in these circumstances.
Stormwater Regulatory Matter
In 2024, the Company entered into a Consent Decree with Los Angeles Waterkeeper (“Waterkeeper”) to settle a citizen suit alleging stormwater-related violations of the Clean Water Act at three Arcadia Products facilities located in Vernon, California. The Consent Decree requires the Company to undertake certain improvements to its stormwater management infrastructure and practices at all three facilities over the next several years.
The Company also has been in contact with the Los Angeles Regional Water Quality Control Board to address certain alleged violations of stormwater regulatory requirements that may be subject to mandatory minimum penalties under applicable California law. The Company cannot predict how this matter will be resolved, but has accrued $408 in aggregate as of March 31, 2026 to address potential claims.
Other Matters
The Company has been notified by a customer of a potential performance issue involving one of NobelClad’s products. As of the date of this report, no legal claim has been asserted, and no legal proceeding has commenced. We are currently evaluating the matter. The Company has determined that a loss related to this matter is reasonably possible; however, we are unable at this time to reasonably estimate the amount or range of any potential loss. Accordingly, no liability has been recorded in the Condensed Consolidated Financial Statements.
Factors that will impact the amount of loss in this matter, if any, include the results of testing, the scope and cost of any product replacement or remediation, the allocation of responsibility among the customer, the Company, and any relevant third-parties, and the extent of available insurance coverage and recoveries.
U.S. Tariffs
On February 20, 2026, the United States Supreme Court issued a ruling invalidating certain tariffs previously imposed under the International Emergency Economic Powers Act (“IEEPA”). On March 5, 2026, the U.S. Court of International Trade issued an additional ruling stating that importers that have paid tariffs under IEEPA are due refunds. The rulings did not determine the scope or mechanics of any potential refunds. The Company is assessing the potential recoverability of tariffs previously paid under the IEEPA, and as of the date of this report, the Company has not recorded any amounts related to potential refunds, as the outcome and timing remain uncertain.
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with our historical Consolidated Financial Statements and notes that are included in our Annual Report filed on Form 10-K for the year ended December 31, 2025.
Unless stated otherwise, all dollar figures are presented in thousands (000s).
Overview
General
DMC Global Inc. (“DMC”, “we”, “us”, “our”, or the “Company”) operates three manufacturing businesses: Arcadia Products, DynaEnergetics and NobelClad, which produce differentiated products and engineered solutions primarily for the construction, energy, and industrial processing markets. Our businesses seek to capitalize on their product and service differentiation to expand profit margins, increase cash flow and enhance shareholder value. Based in Broomfield, Colorado, DMC’s common stock trades on Nasdaq under the symbol “BOOM.”
Arcadia Products
On December 23, 2021, DMC completed the acquisition of 60% of the membership interests in Arcadia Products, LLC, a Colorado limited liability company resulting from the conversion of Arcadia, Inc. (collectively, “Arcadia Products”). Arcadia Products designs, engineers, fabricates, and finishes aluminum framing systems, windows, curtain walls, storefronts, entrance systems, and interior partitions to the commercial construction market. Additionally, Arcadia Products supplies customized windows and doors to the high-end residential construction market.
Cost of products sold for Arcadia Products includes the cost of aluminum, paint, and other raw materials used in manufacturing as well as employee compensation and benefits, manufacturing facility lease expense, depreciation of manufacturing equipment, supplies and other manufacturing overhead expenses.
DynaEnergetics
DynaEnergetics designs, manufactures, markets, and sells perforating systems and associated hardware for the global oil and gas industry. These products are primarily sold to oilfield service companies in the U.S., Europe, Canada, Africa, the Middle East, and Asia. The market for perforating products, which are used during the well completion process, generally corresponds with oil and gas exploration and production activity. Well completion operations are increasingly complex, which in turn has increased the demand for intrinsically-safe, reliable and technically advanced perforating systems.
Cost of products sold for DynaEnergetics includes the cost of metals, explosives and other raw materials used to manufacture shaped charges, detonating products and perforating guns as well as employee compensation and benefits, depreciation of manufacturing facilities and equipment, supplies and other manufacturing overhead expenses.
NobelClad
NobelClad produces explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints for commuter rail cars, ships, and LNG processing equipment. While most demand for our products is driven by maintenance and retrofit projects at existing plants and facilities, new projects for petrochemical processing, oil refining, and aluminum smelting facilities also account for a significant portion of total demand. These industries tend to be cyclical in nature, and the timing of new order inflow remains difficult to predict.
Cost of products sold for NobelClad includes the cost of metals, explosive powders and other raw materials used to manufacture clad metal plates and transition joints as well as employee compensation and benefits, outside processing costs, depreciation of manufacturing facilities and equipment, manufacturing facility lease expense, supplies and other manufacturing overhead expenses.
Factors Affecting Results
•Consolidated net sales were $135,595 in the first quarter of 2026 versus $159,290 in the first quarter of 2025, a decrease of 15%. The decline was attributable to lower sales at all three business segments, as described below.
•Arcadia Products reported net sales of $56,706 in the first quarter of 2026, representing a decrease of 14% compared with the first quarter of 2025. The decrease was primarily attributable to lower sales volumes in longer-cycle commercial and high-end residential markets.
•DynaEnergetics reported net sales of $59,547 in the first quarter of 2026, representing a decrease of 9% compared with the first quarter of 2025. The decline largely resulted from lower sales volumes and a decrease in pricing due to a highly competitive core North American market, which collectively reduced net sales by $6,908. This decrease was partially offset by an increase in international sales of $904 primarily due to project timing.
•NobelClad reported net sales of $19,342 in the first quarter of 2026, representing a decrease of 31% compared with the first quarter of 2025 driven by the timing of large project shipments out of backlog and lower activity levels due in part to the impact of evolving tariff policies.
•The Company’s leverage ratio, calculated in accordance with its credit facility, was 1.76x as of March 31, 2026 in comparison to the maximum ratio permitted of 3.0x. The Company’s adjusted leverage ratio, calculated using net debt, a non-GAAP measure, was 0.76x as of March 31, 2026.
Refer to “Consolidated Results of Operations” and “Business Segment Financial Information” below for additional discussion.
Outlook
Our three manufacturing businesses continue to closely monitor evolving macroeconomic conditions, including the conflict in the Middle East and other geopolitical and economic challenges, such as volatility in global oil and gas markets, persistently elevated interest rates, and evolving global tariff policies. DynaEnergetics and NobelClad serve the upstream and downstream segments of the oil and gas industry, respectively, and continue to address the impacts of volatile crude oil prices. Sales and profitability could be adversely affected if we, or our customers, are unable to mitigate the above described impacts.
Arcadia Products is working to mitigate the impact of elevated interest rates, volatile input costs, and generally lower construction activity in its core regional markets. These factors have created a competitive and challenging bidding environment, which has impacted Arcadia Products’ current ability to fully pass through higher input costs, mainly with respect to aluminum, which recently reached a multi-year high. While the business continues to focus on strengthening its core commercial operations, which generate approximately 75% of the segment’s sales, the current environment is expected to continue impacting Arcadia Products’ net sales and profitability during 2026. An important twelve-month leading indicator for Arcadia Products is the Architectural Billings Index (“ABI”). In March 2026, the ABI for Arcadia Products’ core western U.S. market rose above 50 for the first time since December 2024, indicating that more firms are reporting increased billings than those reporting declining billings.
DynaEnergetics is continuing a series of initiatives designed to reduce costs and increase market share. These efforts are intended to offset volatility in crude oil prices and potentially lower international activity associated with the current conflict in the Middle East. DynaEnergetics also is pursuing growth opportunities in the enhanced geothermal market and has expanded its sales and marketing efforts in certain emerging global shale markets.
At NobelClad, we use backlog, defined as all unfilled firm purchase orders and commitments at a point in time, to assess near-term demand. Most firm purchase orders and commitments are realized and shipped within 12 months. Order backlog increased to $70,308 at the end of the first quarter of 2026, the highest level in more than 15 years and up 12% from $62,612 at the end of the fourth quarter of 2025. We expect shipments of orders associated with the previously announced international petrochemical project to improve NobelClad’s financial performance during 2026. NobelClad is pursuing additional opportunities with the U.S. Navy following its recently announced plans to accelerate its Naval readiness program.
Each of our businesses are evaluating additional mitigation strategies and targeted cost reduction programs if business does not improve as 2026 progresses.
Use of Non-GAAP Financial Measures
In addition to disclosing financial results that are determined in accordance with generally accepted accounting principles in the United States (“GAAP”), the Company also discloses certain non-GAAP financial measures that we use in operational and financial decision making. Non-GAAP financial measures include the following:
•EBITDA: defined as net income (loss) plus net interest, taxes, depreciation and amortization.
•Adjusted EBITDA: excludes from EBITDA stock-based compensation, restructuring expenses and asset impairment charges (if applicable) and, when appropriate, nonrecurring items that management does not utilize in assessing DMC’s operating performance (as further described in the tables below).
•Adjusted EBITDA attributable to DMC Global Inc.: excludes the Adjusted EBITDA attributable to the 40% redeemable noncontrolling interest in Arcadia Products.
•Adjusted EBITDA for DMC business segments: defined as operating income (loss) plus depreciation, amortization, allocated stock-based compensation (if applicable), restructuring expenses and asset impairment charges (if applicable) and, when appropriate, nonrecurring items that management does not utilize in assessing DMC's operating performance.
•Adjusted net income (loss): defined as net income (loss) attributable to DMC Global Inc. stockholders prior to the adjustment of redeemable noncontrolling interest plus restructuring expenses and asset impairment charges (if applicable) and, when appropriate, nonrecurring items that management does not utilize in assessing DMC's operating performance.
•Adjusted diluted earnings per share: defined as diluted earnings per share attributable to DMC Global Inc. stockholders (exclusive of adjustment of redeemable noncontrolling interest) plus restructuring expenses and asset impairment charges (if applicable) and, when appropriate, nonrecurring items that management does not utilize in assessing DMC’s operating performance.
•Net debt: defined as total debt less consolidated cash and cash equivalents per the Condensed Consolidated Balance Sheets.
Management believes providing these additional financial measures is useful to investors in understanding the Company’s operating performance, excluding the effects of restructuring, asset impairment, and other nonrecurring charges, as well as its liquidity. Management typically monitors the business utilizing the above non-GAAP measures, in addition to GAAP results, to understand and compare operating results across accounting periods, and certain management incentive awards are based, in part, on these measures. The presence of non-GAAP financial measures in this report is not intended to suggest that such measures be considered in isolation or as a substitute for, or as superior to, DMC’s GAAP information, and investors are cautioned that the non-GAAP financial measures are limited in their usefulness. Given that not all companies use identical calculations, DMC’s presentation of non-GAAP financial measures may not be comparable to similarly titled measures of other companies.
Consolidated Results of Operations
Three months ended March 31, 2026 compared with three months ended March 31, 2025
| | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | | | | |
| 2026 | | 2025 | | $ change | | % change | |
| Net sales | $ | 135,595 | | | $ | 159,290 | | | $ | (23,695) | | | (15 | %) | |
| Gross profit | 25,443 | | | 41,199 | | | (15,756) | | | (38 | %) | |
| Gross profit percentage | 18.8 | % | | 25.9 | % | | | | | |
| COSTS AND EXPENSES: | | | | | | | | |
| General and administrative expenses | 14,132 | | | 16,674 | | | (2,542) | | | (15 | %) | |
| % of net sales | 10.4 | % | | 10.5 | % | | | | | |
| Selling and distribution expenses | 10,472 | | | 11,626 | | | (1,154) | | | (10 | %) | |
| % of net sales | 7.7 | % | | 7.3 | % | | | | | |
| Amortization of purchased intangible assets | 4,356 | | | 4,763 | | | (407) | | | (9 | %) | |
| % of net sales | 3.2 | % | | 3.0 | % | | | | | |
| | | | | | | | |
| Strategic review and related expenses | — | | | 1,298 | | | (1,298) | | | (100 | %) | |
| | | | | | | | |
| Restructuring expenses | 566 | | | 325 | | | 241 | | | 74 | % | |
| Operating (loss) income | (4,083) | | | 6,513 | | | (10,596) | | | 163 | % | |
| Other expense, net | (45) | | | (218) | | | 173 | | | (79 | %) | |
| Interest expense, net | (1,461) | | | (1,699) | | | 238 | | | (14 | %) | |
| (Loss) income before income taxes | (5,589) | | | 4,596 | | | (10,185) | | | 222 | % | |
| Income tax provision | 1,221 | | | 2,733 | | | (1,512) | | | (55 | %) | |
| Net (loss) income | (6,810) | | | 1,863 | | | (8,673) | | | 466 | % | |
| Less: Net (loss) income attributable to redeemable noncontrolling interest | (745) | | | 1,186 | | | (1,931) | | | 163 | % | |
| Net (loss) income attributable to DMC Global Inc. | (6,065) | | | 677 | | | (6,742) | | | 996 | % | |
| Adjusted EBITDA attributable to DMC Global Inc. | $ | 3,895 | | | $ | 14,391 | | | $ | (10,496) | | | (73 | %) | |
Net sales were $135,595 for the three months ended March 31, 2026, a decrease of 15% compared with the same period in 2025, due to lower sales at all three business segments. Arcadia Products’ net sales decreased 14% as a result of lower sales volumes in longer-cycle commercial and high-end residential markets. DynaEnergetics’ net sales decreased 9% largely resulting from lower sales volumes and a decrease in pricing in its core North American market. NobelClad’s net sales decreased 31% driven by the timing of large project shipments out of backlog and lower activity levels due in part to the impact of evolving tariff policies.
Gross profit percentage was 18.8% compared with 25.9% for the same period in 2025. The decrease was attributable to tariff impacts which resulted in higher input costs at DynaEnergetics and a less favorable project and regional mix at NobelClad. Additionally, the decline in gross profit percentage was impacted by the lower absorption of fixed manufacturing overhead costs at all three business segments as a result of the decreases in net sales.
General and administrative expenses decreased $2,542 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to a decrease in compensation expense of $2,293, lower outside services costs of $156, and a decrease in business-related travel of $92.
Selling and distribution expenses decreased $1,154 for the three months ended March 31, 2026, compared with the same period in 2025, driven by lower bad debt expense of $645, a decrease in compensation expenses of $222, and reduced outside services costs of $112.
Amortization of purchased intangible assets decreased $407 for the three months ended March 31, 2026, compared to the same period in 2025, as the Arcadia Products customer relationship purchased intangible asset is amortized using an accelerated amortization method.
Strategic review and related expenses of $1,298 for the three months ended March 31, 2025 included $932 in professional service fees and $366 in employee retention compensation, including $36 of stock-based compensation.
Restructuring expenses of $566 and $325 for the three months ended March 31, 2026, and 2025, related to employee severance associated with headcount reductions at Arcadia Products and DynaEnergetics.
Operating loss was $4,083 for the three months ended March 31, 2026, compared to operating income of $6,513 in the same period in 2025, primarily due to lower net sales and corresponding gross profit.
Other expense, net of $45 for the three months ended March 31, 2026 primarily related to net realized foreign currency exchange losses. Currency gains and losses can arise when subsidiaries enter into intercompany and third-party transactions that are denominated in currencies other than their functional currency, including foreign currency forward contracts used to offset foreign exchange rate fluctuations on certain foreign currency denominated asset and liability positions.
Income tax provision of $1,221 was recorded on loss before income taxes of $5,589 for the three months ended March 31, 2026, and we recorded an income tax provision of $2,733 on income before income taxes of $4,596 for the three months ended March 31, 2025. Our most significant operations are in the United States, which has a 21% statutory income tax rate, and Germany, which has a 32% combined statutory income tax rate. The mix of income or loss before income taxes between these jurisdictions is one of the primary drivers of the difference between our 21% statutory tax rate and our effective tax rate. Additionally, the effective rates were impacted unfavorably by state taxes and a valuation allowance in the U.S. which results in no benefit for losses generated domestically. The operating results of Arcadia Products that are attributable to the redeemable noncontrolling interest holder are not taxed at DMC, which resulted in a partially offsetting favorable impact to the effective tax rates.
Net loss attributable to DMC Global Inc. for the three months ended March 31, 2026 was $6,065, compared with net income attributable to DMC Global Inc. of $677 for the same period in 2025, primarily due to the factors discussed above.
Adjusted EBITDA decreased for the three months ended March 31, 2026, compared with the same period in 2025, due to the factors discussed above. See “Use of Non-GAAP Financial Measures” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.
| | | | | | | | | | | |
| Three months ended March 31, |
| | 2026 | | 2025 |
| Net (loss) income | $ | (6,810) | | | $ | 1,863 | |
| Interest expense, net | 1,461 | | | 1,699 | |
| Income tax provision | 1,221 | | | 2,733 | |
| Depreciation | 3,715 | | | 3,660 | |
| Amortization of purchased intangible assets | 4,356 | | | 4,763 | |
| EBITDA | 3,943 | | | 14,718 | |
| Stock-based compensation | 902 | | | 1,563 | |
| | | |
| Strategic review and related expenses | — | | | 1,298 | |
| Restructuring expenses | 566 | | | 325 | |
| | | |
| | | |
| | | |
| | | |
| Other expense, net | 45 | | | 218 | |
| Adjusted EBITDA | 5,456 | | | 18,122 | |
| Less: adjusted EBITDA attributable to redeemable noncontrolling interest | (1,561) | | | (3,731) | |
| Adjusted EBITDA attributable to DMC Global Inc. | $ | 3,895 | | | $ | 14,391 | |
Adjusted Net (Loss) Income and Adjusted Diluted Earnings Per Share decreased for the three months ended March 31, 2026, compared with the same period in 2025, due to the factors discussed above. See “Use of Non-GAAP Financial Measures” above for the explanation of the use of non-GAAP measures. The following is a reconciliation of the most directly comparable GAAP measures to Adjusted Net (Loss) Income and Adjusted Diluted Earnings Per Share.
| | | | | | | | | | | | | | | | | |
| | | | | | | Three months ended March 31, 2026 |
| | | | | | | Amount | | Per Share (1) |
Net loss attributable to DMC Global Inc. (2) | | | | | | | $ | (6,065) | | | $ | (0.30) | |
| | | | | | | | | |
| Restructuring expenses, net of tax | | | | | | | 368 | | | 0.02 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| As adjusted | | | | | | | $ | (5,697) | | | $ | (0.28) | |
(1) Calculated using diluted weighted average shares outstanding of 20,066,158.
(2) Net loss attributable to DMC Global Inc. prior to the adjustment of redeemable noncontrolling interest.
| | | | | | | | | | | | | | | | | |
| | | | | | | Three months ended March 31, 2025 |
| | | | | | | Amount | | Per Share (1) |
Net income attributable to DMC Global Inc. (2) | | | | | | | $ | 677 | | | $ | 0.03 | |
| | | | | | | | | |
| Strategic review and related expenses, net of tax | | | | | | | 1,298 | | | 0.07 | |
| Restructuring expenses, net of tax | | | | | | | 195 | | | 0.01 | |
| | | | | | | | | |
| As adjusted | | | | | | | $ | 2,170 | | | $ | 0.11 | |
(1) Calculated using diluted weighted average shares outstanding of 19,816,281.
(2) Net income attributable to DMC Global Inc. prior to the adjustment of redeemable noncontrolling interest.
Business Segment Financial Information
We primarily evaluate performance and allocate resources based on segment revenues, operating income (loss) and Adjusted EBITDA as well as projected future performance. Segment operating income (loss) is defined as revenues less expenses identifiable to the segment. DMC consolidated operating income (loss) and Adjusted EBITDA include unallocated corporate expenses and unallocated stock-based compensation expense. Stock-based compensation is not allocated to wholly owned segments, DynaEnergetics and NobelClad. Stock-based compensation is allocated to the Arcadia Products segment as 60% of such expense is attributable to the Company, whereas the remaining 40% is attributable to the redeemable noncontrolling interest holder. Segment operating income (loss) will reconcile to consolidated income (loss) before income taxes by deducting unallocated corporate expenses, unallocated stock-based compensation, other expense, net, and interest expense, net.
Arcadia Products
Three months ended March 31, 2026 compared with three months ended March 31, 2025
| | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | | | | |
| 2026 | | 2025 | | $ change | | % change | |
| Net sales | $ | 56,706 | | | $ | 65,580 | | | $ | (8,874) | | | (14 | %) | |
| Gross profit | 13,665 | | | 20,361 | | | (6,696) | | | (33 | %) | |
| Gross profit percentage | 24.1 | % | | 31.0 | % | | | | | |
| COSTS AND EXPENSES: | | | | | | | | |
| General and administrative expenses | 6,431 | | | 7,459 | | | (1,028) | | | (14 | %) | |
| Selling and distribution expenses | 4,385 | | | 4,818 | | | (433) | | | (9 | %) | |
| Amortization of purchased intangible assets | 4,356 | | | 4,763 | | | (407) | | | (9 | %) | |
| | | | | | | | |
| | | | | | | | |
| Restructuring expenses | 495 | | | 325 | | | 170 | | | 52 | % | |
| | | | | | | | |
| Operating (loss) income | (2,002) | | | 2,996 | | | (4,998) | | | 167 | % | |
| Adjusted EBITDA | 3,902 | | | 9,327 | | | (5,425) | | | (58 | %) | |
| Less: adjusted EBITDA attributable to redeemable noncontrolling interest | (1,561) | | | (3,731) | | | (2,170) | | | (58 | %) | |
| Adjusted EBITDA attributable to DMC Global Inc. | $ | 2,341 | | | $ | 5,596 | | | $ | (3,255) | | | (58 | %) | |
Net sales decreased $8,874 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to lower sales volumes in longer-cycle commercial and high-end residential markets.
Gross profit percentage decreased to 24.1% for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to lower absorption of fixed manufacturing overhead costs as a result of the decrease in net sales described above.
General and administrative expenses decreased $1,028 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to lower compensation costs of $1,015 as a result of a reduction in headcount and lower incentive compensation.
Selling and distribution expenses decreased $433 for the three months ended March 31, 2026, compared with the same period in 2025, primarily driven by lower incentive compensation costs of $300 and a reduction in bad debt expense of $154.
Amortization of purchased intangible assets decreased $407 for the three months ended March 31, 2026, compared with the same period in 2025, as the customer relationship purchased intangible asset is amortized using an accelerated amortization method.
Restructuring expenses of $495 and $325 for the three months ended March 31, 2026, and 2025, respectively, related to employee severance associated with headcount reductions.
Operating loss was $2,002 for the three months ended March 31, 2026, compared to operating income of $2,996 in the same period in 2025, primarily due to lower net sales and corresponding gross profit.
Adjusted EBITDA decreased for the three months ended March 31, 2026, compared with the same period in 2025, due to the factors discussed above. See “Use of Non-GAAP Financial Measures” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.
| | | | | | | | | | | |
| Three months ended March 31, |
| 2026 | | 2025 |
| Operating (loss) income | $ | (2,002) | | | $ | 2,996 | |
| Adjustments: | | | |
| | | |
| | | |
| Depreciation | 1,029 | | | 1,006 | |
| Amortization of purchased intangible assets | 4,356 | | | 4,763 | |
| Stock-based compensation | 24 | | | 237 | |
| Restructuring expenses | 495 | | | 325 | |
| | | |
| | | |
| | | |
| | | |
| Adjusted EBITDA | 3,902 | | | 9,327 | |
| Less: adjusted EBITDA attributable to redeemable noncontrolling interest | (1,561) | | | (3,731) | |
| Adjusted EBITDA attributable to DMC Global Inc. | $ | 2,341 | | | $ | 5,596 | |
DynaEnergetics
Three months ended March 31, 2026 compared with three months ended March 31, 2025
| | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | | | | |
| 2026 | | 2025 | | $ change | | % change | |
| Net sales | $ | 59,547 | | | $ | 65,551 | | | $ | (6,004) | | | (9 | %) | |
| Gross profit | 7,505 | | | 12,811 | | | (5,306) | | | (41 | %) | |
| Gross profit percentage | 12.6 | % | | 19.5 | % | | | | | |
| COSTS AND EXPENSES: | | | | | | | | |
| General and administrative expenses | 2,640 | | | 2,747 | | | (107) | | | (4 | %) | |
| Selling and distribution expenses | 3,882 | | | 4,476 | | | (594) | | | (13 | %) | |
| | | | | | | | |
| Restructuring expenses | 71 | | | — | | | 71 | | | 100 | % | |
| | | | | | | | |
| Operating income | 912 | | | 5,588 | | | (4,676) | | | (84 | %) | |
| Adjusted EBITDA | $ | 2,746 | | | $ | 7,379 | | | $ | (4,633) | | | (63 | %) | |
Net sales decreased $6,004 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to lower sales volumes and a decrease in pricing due to a highly competitive core North American market, which collectively reduced net sales by $6,908. This decrease was partially offset by an increase in international sales of $904 primarily due to project timing.
Gross profit percentage decreased to 12.6% for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to tariff impacts which resulted in higher input costs as well as lower absorption of fixed manufacturing overhead costs driven by the decrease in net sales in the North American market.
General and administrative expenses were lower by $107 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to a decrease in lease expense.
Selling and distribution expenses were lower by $594 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to a reduction in bad debt expense of $491.
Restructuring expenses of $71 for the three months ended March 31, 2026 related to employee severance associated with headcount reductions.
Operating income of $912 for the three months ended March 31, 2026, decreased compared to operating income of $5,588 in the same period in 2025, primarily due to lower net sales and corresponding gross profit.
Adjusted EBITDA decreased for the three months ended March 31, 2026, compared with the same period in 2025, due to the factors discussed above. See “Use of Non-GAAP Financial Measures” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.
| | | | | | | | | | | |
| Three months ended March 31, |
| 2026 | | 2025 |
| Operating income | $ | 912 | | | $ | 5,588 | |
| Adjustments: | | | |
| | | |
| | | |
| Depreciation | 1,763 | | | 1,791 | |
| | | |
| Restructuring expenses | 71 | | | — | |
| Adjusted EBITDA | $ | 2,746 | | | $ | 7,379 | |
NobelClad
Three months ended March 31, 2026 compared with three months ended March 31, 2025
| | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | | | | |
| 2026 | | 2025 | | $ change | | % change | |
| Net sales | $ | 19,342 | | | $ | 28,159 | | | $ | (8,817) | | | (31 | %) | |
| Gross profit | 4,377 | | | 8,097 | | | (3,720) | | | (46 | %) | |
| Gross profit percentage | 22.6 | % | | 28.8 | % | | | | | |
| COSTS AND EXPENSES: | | | | | | | | |
| General and administrative expenses | 1,168 | | | 1,192 | | | (24) | | | (2 | %) | |
| Selling and distribution expenses | 2,157 | | | 2,283 | | | (126) | | | (6 | %) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Operating income | 1,052 | | | 4,622 | | | (3,570) | | | (77 | %) | |
| Adjusted EBITDA | $ | 1,893 | | | $ | 5,416 | | | $ | (3,523) | | | (65 | %) | |
Net sales decreased $8,817 for the three months ended March 31, 2026, compared with the same period in 2025, driven by the timing of large project shipments out of backlog and lower activity levels due in part to the impact of evolving tariff policies.
Gross profit percentage decreased to 22.6% for the three months ended March 31, 2026 due to lower absorption of fixed manufacturing overhead costs as a result of the decrease in net sales described above as well as a less favorable project and regional mix.
Selling and distribution expenses were lower by $126 for the three months ended March 31, 2026, compared with the same period in 2025, primarily due to decreases in compensation costs of $58 and outside services costs of $39.
Operating income of $1,052 for the three months ended March 31, 2026, decreased compared with operating income of $4,622 in the same period in 2025, primarily due to lower net sales and corresponding gross profit.
Adjusted EBITDA decreased for the three months ended March 31, 2026, compared with the same period in 2025, due to the factors discussed above. See “Use of Non-GAAP Financial Measures” above for the explanation of the use of Adjusted EBITDA. The following is a reconciliation of the most directly comparable GAAP measure to Adjusted EBITDA.
| | | | | | | | | | | |
| Three months ended March 31, |
| 2026 | | 2025 |
| Operating income | $ | 1,052 | | | $ | 4,622 | |
| Adjustments: | | | |
| Depreciation | 841 | | | 794 | |
| | | |
| | | |
| Adjusted EBITDA | $ | 1,893 | | | $ | 5,416 | |
Liquidity and Capital Resources
We have historically financed our operations from a combination of internally generated cash flow, revolving credit borrowings, and various long-term debt arrangements. Our net debt position was $22,443 at March 31, 2026, compared with $18,746 at December 31, 2025. The increase was primarily due to net credit facility borrowings of $3,200 to partially fund the payment of incentive compensation earned in 2025.
We believe that cash and cash equivalents on hand, cash flow from operations, funds available under our current credit facilities and any future replacement thereof will be sufficient to fund the working capital, required minimum debt service payments, and other capital expenditure requirements of our current business operations for the foreseeable future. We may also execute capital markets transactions, including at-the-market offering programs, to raise additional funds if we believe market conditions are favorable, but there can be no assurance that any future capital will be available on acceptable terms or at all. Nevertheless, our ability to generate sufficient cash flows from operations will depend upon our success in executing our strategies. If we are unable to (i) realize sales from our backlog; (ii) secure new customer orders; (iii) continue selling products at profitable margins; and (iv) continue to implement cost-effective internal processes, our ability to meet cash requirements through operating activities could be impacted. Furthermore, any restriction on the availability of borrowings under our credit facilities could negatively affect our ability to meet future cash requirements. We will continue to monitor our short-term and long-term liquidity needs, which could be affected by financial market conditions, including the related impact on credit availability and capital markets.
Debt facilities
On February 6, 2024, the Company and certain domestic subsidiaries entered into an amendment (the “First Amendment”) to its existing credit agreement with a syndicate of banks, led by KeyBank National Association (the “credit facility”). The First Amendment provided for certain changes to the credit facility and increased the maximum commitment amount from $200,000 to $300,000. The credit facility originally allowed for revolving loans of up to $200,000, a $50,000 term loan facility, and a $50,000 delayed draw term loan (“DDTL”) facility. On February 6, 2026, the ability of the Company to access the $50,000 DDTL facility expired per the terms of the First Amendment. The $50,000 term loan facility is payable in installments of $938 per quarter through March 31, 2028. Quarterly term loan payments increase to $1,250 from June 30, 2028, through December 31, 2028. A balloon payment for the outstanding term loan balance is due upon the credit facility maturity date of February 6, 2029. The credit facility retains a $100,000 accordion feature to increase the commitments under the revolving loan and/or by adding one or more term loans subject to approval by the applicable lenders. The credit facility is secured by certain assets of DMC including accounts receivable, inventory, and fixed assets, including Arcadia Products and its subsidiary, as well as guarantees and share pledges by DMC and its subsidiaries.
Borrowings under the $200,000 revolving loan limit and $50,000 term loan can be in the form of SOFR loans or one month Adjusted Term SOFR loans. Additionally, U.S. dollar borrowings on the revolving loan can be in the form of Base Rate loans (Base Rate borrowings are based on the greater of the administrative agent’s Prime rate, an adjusted Federal Funds rate or an adjusted SOFR rate). SOFR loans bear interest at the applicable SOFR rate plus an applicable margin (varying from 2.25% to 3.25%). Base Rate loans bear interest at the defined Base Rate plus an applicable margin (varying from 1.25% to 2.25%).
The credit facility includes various covenants and restrictions, certain of which relate to the payment of dividends or other distributions to stockholders; redemption of capital stock; incurring additional indebtedness; mortgaging, pledging or disposition of major assets; and maintenance of specified ratios. As of March 31, 2026, we were in compliance with all financial covenants and other provisions of our debt agreements.
The leverage ratio is defined in the credit facility as the ratio of Consolidated Funded Indebtedness (as defined in the credit facility) on the last day of any trailing four quarter period to Consolidated EBITDA (as defined in the credit facility) for such period. The maximum leverage ratio permitted by our credit facility is 3.0 to 1.0; provided, however, that the Second Amendment (as defined below) provides for a temporary increase in the maximum leverage ratio under certain circumstances as described below. The actual leverage ratio as of March 31, 2026 was 1.76 to 1.0.
The debt service coverage ratio is defined in the credit facility as the ratio of Consolidated EBITDA less the sum of capital distributions paid in cash (other than those made with respect to preferred stock issued under the Operating Agreement), Consolidated Unfunded Capital Expenditures (as defined in the credit facility), and net cash income taxes divided by the sum of cash interest expense, any dividends on the preferred stock paid in cash, and scheduled principal payments on funded indebtedness. Under our credit facility, the minimum debt service coverage ratio permitted is 1.25 to 1.0. The actual debt service coverage ratio for the trailing twelve months ended March 31, 2026, was 2.12 to 1.0.
On June 10, 2025, the Company and certain domestic subsidiaries entered into an amendment to the credit facility (the “Second Amendment”) which provided for certain changes to the credit facility, including modifications to the Company’s financial covenants and applicable interest rates to assist with the possible acquisition of the remaining 40% minority interest in Arcadia Products. Key provisions of the Second Amendment include a temporary increase in the Company’s maximum leverage ratio to 3.5x adjusted EBITDA over the trailing 12 months — up from 3.0x — should either the Put Option or the Call Option be exercised. This elevated leverage limit will apply for the first two quarters following payment of the purchase price of the Put Option or the Call Option, followed by a reduction to 3.25x in the third quarter, and a return to 3.0x thereafter.
As of March 31, 2026, borrowings of $45,000 on the term loan under our credit facility were outstanding, and $10,200 was outstanding on the revolver.
We also maintain a line of credit with a German bank for certain European operations. This line of credit provides a borrowing capacity of €7,000. As of March 31, 2026, we had no outstanding borrowings, and bank guarantees of €2,876 were secured.
Redeemable noncontrolling interest
The Operating Agreement for Arcadia Products contains a right for the Company to purchase the remaining interest in Arcadia Products from the minority interest holder on or after December 23, 2024 (“Call Option”). The minority interest holder of Arcadia Products also has the right to sell its remaining interest in Arcadia Products to the Company (“Put Option”). On December 3, 2024, the Company and minority interest holder entered into an amendment to the Operating Agreement whereby the minority interest holder agreed not to exercise the Put Option until on or after September 6, 2026.
The purchase price for any interests sold pursuant to the Call Option or Put Option continues to be based upon a predefined calculation as included within the Operating Agreement. In connection with an exercise of the Call Option, the Operating Agreement would require payment of the purchase price in cash. However, in connection with the exercise of the Put Option, the Operating Agreement permits the Company the option to pay the purchase price in either cash, or 20% in cash and 80% in shares of a newly designated series of preferred stock (the “Put Preferred”) that would be authorized at that time. The terms of the Put Preferred, including the rights, powers and preferences thereof, are set forth in the Operating Agreement. The number of shares to be issued in connection with the Put Option (if the Company utilizes that payment mechanism) would be initially determined and valued at the volume weighted average trading price of the Company’s common stock over the 60 days preceding the delivery of the Put Option notice. The Put Preferred would be entitled to dividends at a rate of 3% per annum and would be convertible into one share of the Company’s common stock, subject to Nasdaq rules which generally prohibit private placements of equity securities with voting rights of 20% or more of a company’s pre-issuance voting power, including through convertible securities, without stockholder approval; the holder of the Put Preferred would not be allowed to participate in any such stockholder vote. The Company may redeem the Put Preferred at any time; however, beginning on June 23, 2027, the Company must begin proportionate annual redemptions of the Put Preferred and, in any event, the Put Preferred must be redeemed by the third anniversary of its issuance.
As of March 31, 2026, the value of the redeemable noncontrolling interest under the Operating Agreement was $187,080. Upon settlement, consideration paid will be net of the $24,902 promissory note outstanding due from the redeemable noncontrolling interest holder and is subject to potential working capital adjustments. Refer to Note 2 in Part I, Item 1 for further information related to the valuation of the redeemable noncontrolling interest and promissory note outstanding. We are currently evaluating options for financing the purchase of the noncontrolling interest, which may include cash generated from operations, borrowings under the credit facility, and/or proceeds from debt or equity issuances. Debt financing could materially impact the Company’s leverage while equity financing could materially dilute existing stockholders.
Other contractual obligations and commitments
Our debt balance, net of deferred debt issuance costs, increased to $53,954 at March 31, 2026, from $50,644 at December 31, 2025, for the reasons discussed above. Our other contractual obligations and commitments have not materially changed since December 31, 2025.
Cash flows from operating activities
Net cash used in operating activities was $2,379 for the three months ended March 31, 2026, compared to net cash provided by operating activities of $4,488 in the same period last year. The decrease in the current year was largely driven by higher working capital balances, which included increased inventory balances at all three business segments given an expectation of near-term activity level increases, as well as higher aluminum costs at Arcadia Products.
Cash flows from investing activities
Net cash used in investing activities for the three months ended March 31, 2026, and 2025, of $1,263 and $3,332, respectively, was attributable to the acquisition, net of proceeds received, of property, plant and equipment.
Cash flows from financing activities
Net cash provided by financing activities for the three months ended March 31, 2026 of $2,833 included net credit facility borrowings of $3,200, which were partially offset by treasury stock purchases of $367.
Net cash used in financing activities for the three months ended March 31, 2025 of $135 included distributions to the redeemable noncontrolling interest holder of $1,151 and treasury stock purchases of $484, which were partially offset by net credit facility borrowings of $1,500.
Payment of Dividends
Any determination to pay cash dividends is at the discretion of the Board of Directors. Future dividends may be affected by, among other items, our views on potential future capital requirements, future business prospects, debt covenant compliance considerations, changes in income tax laws, and any other factors that our Board of Directors deems relevant.
Critical Accounting Estimates
Preparation of financial statements in conformity with generally accepted accounting principles in the United States requires that management make estimates, judgments and assumptions that affect the amounts reported for revenues, expenses, assets, liabilities, and other related disclosures. Our critical accounting estimates have not changed from those reported in Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
ITEM 3. Quantitative and Qualitative Disclosure about Market Risk
There were no material changes in market risk for changes in foreign currency exchange rates and interest rates from the information provided in Item 7A – Quantitative and Qualitative Disclosures About Market Risk in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.
ITEM 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer have evaluated the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, as amended, as of the end of the period covered by this report, and they have concluded that these controls and procedures are effective.
Changes in Internal Control over Financial Reporting
There were no changes that occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II - OTHER INFORMATION
Item 1. Legal Proceedings
Refer to Note 11 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this report.
Item 1A. Risk Factors
There have been no material changes in the risk factors identified as being attendant to our business in our Annual Report on Form 10-K for the year ended December 31, 2025, except as provided below.
The conflict between the United States, Israel and Iran and related geopolitical instability may adversely affect our business.
In February 2026, the United States and Israel launched coordinated military strikes against Iran, which retaliated with missile attacks across the region. Although we do not have operations in the Middle East, the ongoing conflict and any further escalation, including additional military actions, retaliatory measures, sanctions, disruptions to trade or transportation routes, cyberattacks, or other governmental or market responses, has and could continue to lead to significant disruption of global energy supplies and increases in global energy prices, heighten inflationary pressures on our input costs and supply chain, adversely affect global supply chains, energy markets, commodity prices, currency exchange rates, interest rates, financial markets and overall macroeconomic conditions, increase the cost or reduce the availability of debt financing, and adversely impact customer spending patterns in markets in which we operate. In particular, the price of aluminum, the most important raw material for Arcadia Products, has increased to a multi-year high in part due to the ongoing conflict and the difficulty in sourcing and transporting this material. While the impacts of conflict between the United States, Israel, and Iran may have an adverse effect on our business, financial condition and results of operations, we are unable to predict the extent or nature of these impacts at this time.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
In connection with the vesting of Company restricted common stock under our equity incentive plans or distributions of shares of common stock pursuant to our Amended and Restated Non-Qualified Deferred Compensation Plan (“deferred compensation plan”) during the first quarter of 2026, we retained shares of common stock in satisfaction of withholding tax obligations. We also retained shares of common stock as the result of participants’ diversification of equity awards held in the deferred compensation plan into other investment options. These shares are held as treasury shares by the Company.
| | | | | | | | | | | | | | |
| | Total number of shares purchased (1) (2) | | Average price paid per share |
January 1 to January 31, 2026 | | — | | | $ | — | |
February 1 to February 28, 2026 | | 26,813 | | | $ | 6.90 | |
March 1 to March 31, 2026 | | 38,572 | | | $ | 4.73 | |
| Total | | 65,385 | | | $ | 5.62 | |
(1) Share purchases during the period were to offset tax withholding obligations that occurred upon (i) vesting of restricted common stock under the terms of the 2016 Omnibus Incentive Plan and the 2025 Omnibus Incentive Plan, as applicable, and (ii) distributions of shares of common stock pursuant to deferred compensation obligations.
(2) As of March 31, 2026, the maximum number of shares that could be purchased would not exceed the employees’ portion of taxes to be withheld on unvested shares (1,378,219) and potential purchases upon participant elections to diversify equity awards held in the deferred compensation plan (3,099) into other investment options available to participants in the deferred compensation plan.
Item 5. Other Information
During the quarter ended March 31, 2026, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).
Item 6. Exhibits
| | | | | |
Exhibit Number | Exhibit Description |
| |
| |
| |
| |
| 4.1 | |
10.1† | |
10.2† | |
10.3† | |
10.4† | |
10.5† | |
10.6† | |
10.7† | |
10.8† | |
10.9† | |
10.10† | |
| 31.1* | |
| 31.2* | |
| 32.1** | |
| 32.2** | |
101.INS | Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH* | Inline XBRL Schema Document |
| 101.CAL* | Inline XBRL Calculation Linkbase Document |
| 101.LAB* | Inline XBRL Label Linkbase Document |
| 101.PRE* | Inline XBRL Presentation Linkbase Document |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) |
__________________
| | | | | |
| |
| * | Filed with this report. |
| ** | Furnished with this report. |
† | Exhibit constitutes a management contract or compensatory plan or agreement. |
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | | | | | | |
| | | DMC Global Inc. |
| | | (Registrant) |
| | | |
| Date: | April 30, 2026 | | /s/ Eric V. Walter |
| | | Eric V. Walter, Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer) |
| | | |
| Date: | April 30, 2026 | | /s/ Brett Seger |
| | | Brett Seger, Chief Accounting Officer (Duly Authorized Officer and Principal Accounting Officer) |